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Electrokinetic transport in brain tissue represents the movement of molecules due to an applied 
electric field and the interplay between the electrophoretic and electroosmotic velocities that are 
developed. This dissertation provides a framework for understanding electrokinetic transport and 
how it may be utilized for short-distance ejections, relevant to capillary iontophoresis, and long-
distance infusions, for the clinical management of malignant brain tumors as a novel convection-
enhanced drug delivery system. 
In particular, electrokinetic transport was first analyzed in a series of poly(acrylamide-co-
acrylic acid) hydrogels that demonstrated varying electroosmotic velocities. Moreover, a 
hydrogel was synthesized to mimic the electrokinetic properties of organotypic hippocampal 
slice cultures (OHSC), as a surrogate for brain tissue. Short- and long-distance capillary 
infusions of molecules into the hydrogels and OHSC provided a framework to understand the 
relevant phenomena, such as the effect of varying the capillary tip size, applied electrical current, 
ζ-potential of the capillary or the outside matrix, infusion time, tortuosity, and properties of the 
solute (including molecular weight and electrophoretic mobility). Control of the directional 
transport of molecules was also demonstrated over a distance of several hundred micrometers to 
millimeters. Finally, electrokinetic infusions were conducted in vivo in the adult rat brain, with 
results compared to those of pressure-driven infusions. 
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Amir Hussein Faraji, Ph.D. 
University of Pittsburgh, 2011
 v 
The experiments and results described in this dissertation provide a foundation for further 
development, by presenting a methodical means to increase the ejection profile and attain 
clinically relevant penetration distances while minimizing adverse effects to the brain tissue, 
including from the electric field itself. The rate of electrokinetic transport is greater than the rate 
of diffusion, and therefore it represents a novel form of convection-enhanced drug delivery 
system. 
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1.0  ELECTROKINETIC AND DIFFUSIONAL TRANSPORT IN BRAIN TISSUE 
1.1 ELECTRIC FIELDS IN BRAIN TISSUE 
Brain tissue is a conductive and electrically active matrix, and it creates endogenous electric 
fields during neuronal communication. For instance, highly localized electric fields are developed 
in synapses laden with ion channel transport proteins.1 Confined electric fields also occur where 
extracellular electrical potential fluctuations contribute to synchronous neuronal firing, such as 
with paracrine-type neurotransmitter release.2 Furthermore, the laminar structure of the 
hippocampus has been shown to generate endogenous extracellular electric fields of tens of 
millivolts per millimeter by the synchronous activation of multiple neurons, with amplification 
due to the orientation of neurons.3, 4 An extreme example of the electroactive nature of brain 
tissue is seizures. Often, a single epileptogenic focus may trigger a rapid cascade of neuronal 
depolarization and seizure activity.5 These foci may be due to the presence of a tumor, blood 
vessel malformation, inflammation, or even fibrosis.5 
Leão first described slowly propagating waves of transitory neuronal and glial 
depolarization – referred to as spreading depression – in 1944.6 Spreading depression is 
characterized by the termination of all spontaneous or evoked synaptic activity and substantial 
K+ efflux into the extracellular space, escalating to concentrations exceeding 40 to 50 mM 
(normal cerebrospinal fluid concentration is 5 to 6 mM).7 This is exacerbated by cellular edema 
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and concomitant shrinkage of the extracellular space, as water enters the cells coupled to Na+ 
influx. The elevated extracellular K+ concentration is thought to depolarize neighboring cells, 
with a propagating wave progressing through contiguous gray matter at an average velocity of 3 
mm/min, irrespective of functional or arterial territories.8 Spreading depression is initiated when 
the regional extracellular K+ concentration exceeds a threshold of 10 to 12 mM in a minimum 
critical volume (~1 mm3 in rodents)6 due to cerebral ischemia and trauma,9-11 elevated 
concentrations of excitatory amino acids (such as glutamate interacting through N-methyl-D-
aspartate (NMDA) receptors),12, 13 and/or functional inhibition or genetic mutation of the 
Na+/K+-ATPase pump.14-18 The K+ depolarization threshold is determined genetically and 
believed to be lower in patients with a propensity for developing migraines, where spreading 
depression is understood to play a part in migraine auras and even as a trigger for headache 
development itself.18 The example of spreading depression underscores the physiological 
uniqueness of the brain, and its propensity to develop endogenous electric fields. 
1.2 ELECTROOSMOSIS AND ELECTROPHORESIS 
In 1964, Ranck theorized that electroosmotic flow might be developed in the extracellular space 
of brain tissue solely due to endogenous synaptic firing.19 As described by Ranck, “when electric 
current flows in a liquid which is surrounded by a substance with a surface charge, the liquid will 
move. This is the phenomenon of electroosmosis.”19 In other words, electroosmosis is the bulk 
fluid flow that is stimulated when an electric field is applied in a matrix with a non-zero ζ-
potential.20 The ζ-potential is the electrical potential that exists at the slip plane between mobile 
ions that are associated with a charged surface and the fixed surface charges.20 In brain tissue and 
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other biological matrices, this ζ-potential is a result of cell membrane phospholipid head groups, 
proteins, carbohydrates, and other components of the extracellular matrix that are bound to the 
cell.21 Ranck estimated the ζ-potential of brain tissue to be -15 mV,19 which is now known to be 
a lower magnitude than the experimentally determined value and furthermore understated the 
extent of electroosmosis.22 
Electrokinetic transport results from the application of an electric field across a porous 
matrix, such as brain tissue. This transport depends on key properties of the matrix and solute 
itself. Of note, two related modes of transport occur – electrophoresis and electroosmosis. 
Electrophoresis represents the movement of charged solute under the influence of an applied 
electric field, traditionally for separation and analysis. In contrast, electroosmosis is the bulk 
fluid flow that is stimulated when an electric field is applied in a matrix with a non-zero ζ-
potential. In other words, electroosmosis is the movement of the solvent, while electrophoresis is 
the movement of the solute in relation to an applied electric field. 
The cells and other components of the extracellular matrix create narrow channels 
through the extracellular space that display an inherent ζ-potential. The resistance to current flow 
is lower through these extracellular channels than through the cells themselves. Thus, it is 
through these channels that electroosmosis occurs. To understand the phenomenon simply, the 
channels through the biological extracellular space may be compared to a cylindrical tube with a 
ζ-potential at its walls, as exists within silica capillaries.20 When an aqueous solution at 
physiological pH is in contact with the silica capillary, the silanol functional groups become 
ionized (with development of the ζ-potential). This results in counterion attraction to the 
capillary walls and development of an electrical “double layer,” effectively leaving the bulk 
solution with a net charge.20, 23 The passage of this charged solution through the capillary 
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represents both a portion of the electrical current and the concomitant transport of the bulk 
solution.23 If the ζ-potential is negative, as with brain tissue and silica capillaries, the bulk fluid 
demonstrates an effective positive charge near the capillary walls. Therefore, the direction of 
electroosmosis is aligned with the path of positive current flow. 
Many models exist to describe the electrical double layer formed at the boundary 
between the capillary wall and bulk solution. The earliest theoretical description of this 
phenomenon was devised by Helmholtz in 1879, in which he mathematically treated the double 
layer as a simple capacitor with ions adsorbed onto the surface.24 Gouy and Chapman advanced 
this understanding with the development of a diffuse model, where the electrical potential at the 
surface decreases exponentially due to adsorbed counter ions from the solution.25, 26 The classical 
electrical double layer is described by Stern model, as shown in Figure 1.1, which incorporates 
the Helmholtz and Gouy-Chapman models as two ion layers.27 Convention holds that the fixed 
Helmholtz layer is termed the “Stern layer” or “compact layer” and the dispersed Gouy-
Chapman layer is termed the “diffuse layer.” Some important approximations used in the Stern 
model are that ions are considered as point charges, that only electrostatic interactions are 
significant, that a constant electrical permittivity exists throughout the double layer, and that the 
solvent molecule distribution is uniform. The thickness of the double layer depends on the ζ-
potential magnitude and ionic strength of the solution, typically ranging from less than 1 to 10 
nm in aqueous solutions.20 At further distances from the capillary wall, the ion distribution in the 
bulk solution reaches electroneutrality. 
Electroosmosis is related to the observed velocity, vobs, of a solute under the influence of 
an electric field, E, by the Helmholtz-Smoluchowski equation, provided as Equation 1.1.  
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vobs  veo   E  eoE  1.1
Equation 1.1 demonstrates that vobs is equivalent to the electroosmotic velocity, veo, for a 
neutrally charged solute. The velocity is related to the ζ-potential, ζ, where ε and η are the 
permittivity and viscosity of the medium, respectively. Moreover, the electroosmotic mobility, 
μeo, is directly related to the ζ-potential of the medium. Thus, for a given medium, veo of a solute 
is dependent on the ζ-potential of that medium and the applied electric field. However, if the ζ-
potential cannot be altered, such as in brain tissue with physiological pH and ionic strength, veo is 
solely dependent on the applied electric field. For charged solutes, vobs is not equal to veo. A new 
term – the electrophoretic velocity, vep – needs to be introduced. The surface charges on a 
particle define its ζ-potential analogous to the silica capillary, with a slip plane between closely 
adherent and diffusely associated counterions. Equation 1.2 relates this ζ-potential, ζparticle, to vep, 
where μep is the electrophoretic mobility. 
vep 
particle
 E  ep E  1.2 
In this equation, the migration of a charged particle under an applied electric field, 
independent of the ζ-potential of the medium, is electrophoresis. Values of μep can be determined 
for compounds by capillary electrophoresis. The observed velocity for charged compounds is the 
vector sum of two resultant velocity vectors (vep and veo), and the observed mobility is the sum of 
the two mobilities (μep and μeo). Therefore, a molecule does not move when μep is directly 
opposed and of equal magnitude to μeo. 
Though the silica capillary provides a model for understanding electrokinetic transport, 
the brain extracellular space expresses some differences. This is because the channel through a 
capillary has a fixed diameter with a relatively smooth surface, whereby the charge density at the 
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capillary walls remains relatively constant. However, the channels through the brain extracellular 
space are highly variable and may contain sharp turns and bends which may create local 
variability in the electric field, double layer thickness, and resulting electroosmosis. On a more 
macroscopic scale (the scale of the experiments presented in this dissertation), the electrokinetic 
variability between each extracellular channel does not have an effect on the average direction of 
transport. On this macroscopic scale, the individual mobilities within each channel are averaged 
together with the resultant macroscopic velocity vector having a much larger magnitude than the 
microscopic variability between channels. Thus, while the degree of bending in the extracellular 
space may not impact the overall direction of the macroscopic velocity vector, it may decrease 
the magnitude of the macroscopic velocity vector. This is addressed in the next section, by 
introduction of the tortuosity. 
	
 
 
Figure 1.1. Electroosmosis in a silica capillary (A) and the electrical "double layer” (B).
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1.3 TORTUOSITY AND HINDERED DIFFUSION 
In the brain tissue, a compound must move throughout the tissue independent of an applied 
electric field. The tortuosity represents a quantification of the “twists and bends” within the 
extracellular space, as viewed from the perspective of a molecule.28 The tortuosity was first 
described as the effective distance a solute must travel between two points in the extracellular 
space divided by the linear distance between those two points irrespective of any obstacles.29 The 
distance a solute travels in a medium in the absence of any convective forces is related to the 
molecule’s diffusion coefficient. 
Diffusion is the net transport of a molecule along a chemical potential gradient by 
random molecular motion over small distances, as described initially by Fick.30 The diffusion 
coefficient (D) of a molecule may be determined by the Stokes-Einstein equation, shown in 
Equation 1.3, 
D  kBT
f
 kBT
6r  1.3 
where kB is Boltzmann’s constant, T is temperature, and f is the friction coefficient of the 
medium of interest. In particular, the friction coefficient is related to the viscosity of the medium, 
η, and the hydrodynamic radius, r, of the spherical particle.31 From Fick’s law of diffusion and 
the Stokes-Einstein equation, rates of diffusion depend on temperature, the viscosity of the 
medium, the magnitude of the chemical potential gradient, and the size (hydrodynamic radius) of 
the diffusing molecules. The rate of diffusion is slower when the friction coefficient is high, such 
as in a highly viscous medium, with large molecules, or at low temperatures; the converse holds 
for rapid diffusion. In contrast, convection represents another form of mass transport, which 
describes movement based on a physical or mechanical force, such as an applied pressure or 
 8 
application of an electric field. Thus, the rate of transport due to convection is greater than the 
rate of transport due to diffusion. At a given point in time, convection results in a greater tissue 
distribution and transport than is achieved by diffusion alone. In contrast, the solute distribution 
in tissue achieved by convection and diffusion is limited by the size of the tissue itself, as the 
time scale approaches infinity. 
In brain tissue, the extracellular space is not empty; rather, it is full of proteins, 
proteoglycans, and structural proteins such as collagen and elastin that surround large cells. 
Small molecules are able to more easily pass around these barriers when diffusing through the 
extracellular space as compared to larger, bulky molecules. This results in “hindered diffusion” 
for the larger molecules. Accordingly, a new definition for the tortuosity was related to a ratio of 
the diffusion coefficients for a molecule in free solution to a molecule in an obstructed medium 
(i.e.: the tissue of interest), as given by Equation 1.4 where λ is the tortuosity, D is the diffusion 
coefficient in free solution, and D* is the apparent diffusion coefficient in the medium of 
interest.28 
  D
D*
 
1.4 
The tortuosity has been extensively studied in brain tissue by examining the diffusion of 
tetramethylammonium ion,32-58 dextrans,36, 59-62 other polymers,63-65 albumin,60 radiotracers,66-69 
neurotransmitters,33 and other molecules.44, 61, 70-75 Variability in the makeup of the extracellular 
space amongst tissue types and regions may occur, and thus tortuosity values may also vary.33, 42, 
43, 61 
The apparent diffusion coefficient in the medium, and thus the tortuosity, is influenced by 
the composition of the brain tissue extracellular space and the size and shape of the molecule. As 
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a result, this definition of tortuosity, developed by neuroscientists,28 introduces an additional 
concept beyond a ratio of distances between two points – a frictional drag force – that acts to 
retard the progress of a diffusing molecule. The Stokes-Einstein equation accounts for the 
viscosity of the medium in determining the diffusion coefficient, and therefore introduction of 
this frictional drag force into the definition of tortuosity may be analogous to increasing the 
viscosity of the medium in the Stokes-Einstein equation. The frictional drag force may result 
from steric effects,76 reptation77 and entropic barrier transport78 of flexible linear molecules, or 
due to changes in the extracellular space itself. 
In 1958, Ogston introduced a model to describe the migration of a spherical molecule 
through a randomly-oriented interconnected matrix of immobile fibers by accounting for the 
steric effects introduced by that matrix on molecular transport,76 which was later adapted to also 
describe the migration of nonspherical molecules.79 In addition to this steric effect, reptation 
represents the “wormlike” movement of flexible linear molecules inside a matrix that is strongly 
cross-linked.77 In a porous, heterogeneous matrix such as brain tissue, the extracellular space has 
different volumes (this is, the tissue has variable densities). With a larger extracellular space, a 
flexible linear molecule has an opportunity to become coiled and entangled.77, 80 The degree of 
possible entanglement in a given matrix is related to the length of the macromolecule.80 Thus, 
rather than simply moving through a heterogeneous matrix, flexible linear molecules may also 
fold upon themselves. Moreover, when the size of each entangled coil approximates the size of 
the voids within a matrix due to its heterogeneity, local entropic gradients become prominent and 
the molecule preferentially positions itself in the voids.78, 81 Accordingly, these three processes 
may also be accounted for in the frictional drag force, especially for the large 70 kDa fluorescent 
dextran conjugates utilized in this dissertation. 
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Furthermore, this frictional drag force may be introduced as a result of changes in the 
diameter of the channels through a matrix, such as with the extracellular space in vivo. In the 
case of brain tissue, the diameter of the channels through the cortical extracellular matrix in vivo 
was determined to be 38 to 64 nm under homeostatic conditions, but only 10 nm after cardiac 
arrest.61 Thus, a nanoparticle or macromolecule with globular size greater than 10 nm would not 
physically fit through the cortical extracellular matrix channels in ischemic tissue. This result for 
cardiac arrest is interesting and perhaps a product of vasoconstriction within the peripheral 
vasculature with a resultantly greater volume of blood within the internal organs, including the 
brain, due to activation of the sympathetic nervous system. The volumetric distribution of 
intracranial components is described by the Monro-Kellie hypothesis,82-84 whereby the total 
intracranial volume is fixed and is a sum of the volumes of brain tissue (~80% of the total 
volume), cerebrospinal fluid (~10% of the total volume), and blood (~10% of the total volume). 
Thus, if the intracranial volume of blood increases, then the volumes of brain tissue and 
cerebrospinal fluid must correspondingly decrease by the same amount. Because the in vivo brain 
tissue is slightly compressed and the volume of cerebrospinal fluid decreases due to this increase 
in blood supply, the extracellular channels decrease in diameter. The frictional drag force for 
transport in this situation may correspondingly increase. 
Moreover, the brain demonstrates significant anisotropy resulting from regional tissue 
architecture. The gray matter is composed of primarily neuronal cell bodies and glial cells, and 
the effective diffusivity in gray matter is isotropic.85 In contrast, the white matter contains 
bundles of axons that project from those cell bodies and show directional orientation. 
Consequently, the effective diffusivity in white matter is anisotropic.86-88 This principle governs 
fiber tracking in diffusion tensor imaging magnetic resonance imaging.86-88 For the purposes of 
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transporting molecules through the white matter of the brain, the frictional drag force depends on 
the orientation of transport to the axonal bundles. Therefore, transport aligned with the bundle 
projections produces a smaller frictional drag force compared to transport perpendicular to the 
plane of the bundles. 
Finally, the frictional drag force also accounts for the biochemical interactions of a 
molecule with the brain tissue milieu. In particular, if a drug is to be transported, the effects of 
decomposition by enzymatic processes, clearance due to vascular or cellular uptake, and 
immobilization and binding to receptors must all be considered.85 As one example of this 
phenomenon, consider the diffusional transport of a molecule that undergoes reversible binding 
to a cell surface receptor. The observed diffusion coefficient can therefore be estimated by a 
weighted-average of the proportion of time the molecule spends between the bound and unbound 
states. By extension, the frictional drag force is higher when the molecule remains bound to the 
receptor for a longer time. Finally, the rate of fluid clearance from the given volume of brain 
tissue in vivo (such as for fluid introduced by an infusion) ranges from approximately 0.3 to 0.5 
μL min-1 mL-1.89 
Therefore, the frictional drag force included in D* includes processes such as steric 
effects, reptation, entropic barrier transport, variations in extracellular matrix channel diameter, 
tissue anisotropy due to architectural regions, and biochemical interactions. This drag force may 
also exist during molecular transport by convection, since it represents the effect of the tissue 
itself on a particular molecule’s motion. For subsequent discussions in this dissertation, the 
tortuosity is defined by Equation 1.4, which includes the frictional drag force. 
 12 
1.4 MEASUREMENT OF THE ZETA-POTENTIAL AND TORTUOSITY 
These fundamental phenomena – electrophoresis, electroosmosis, and tortuosity – are essential to 
understand when electrokinetically transporting a molecule through the brain extracellular space. 
As mentioned previously, Ranck estimated the ζ-potential of brain tissue to be -15 mV to further 
determine whether electroosmosis existed within and adjacent to synapses.19 To more accurately 
understand electroosmosis in brain tissue, its ζ-potential must be experimentally quantified. 
Moreover, for macroscopic bulk transport of molecules through the extracellular space, the 
tortuosity must also be quantified. Our lab previously developed a methodology for measurement 
of the ζ-potential and tortuosity in brain tissue using organotypic hippocampal slice cultures 
(OHSC) as an in vitro surrogate for brain tissue.21, 22 
1.4.1 Organotypic Hippocampal Slice Cultures 
The hippocampus lies deep in the brain, and comprises the medial aspects of the temporal 
lobes in humans. It is part of the limbic system of the brain and plays an essential role in 
learning, spatial navigation, and long-term memory.90 Furthermore, the hippocampus is 
susceptible to damage in Alzheimer’s disease, epilepsy, traumatic brain injury, and ischemia.90 
OHSC are used in neuroelectrophysiology and neuropharmacology as a model surrogate for 
brain tissue,91 as they are relatively easy to obtain and culture with a preserved tissue architecture 
comprised of neurons and glial cells. 
The OHSC preserves the laminar structure of the hippocampus with intact circuitry, as 
shown in Figure 1.2. The cornu ammonus (CA) is composed of pyramidal neurons and is divided 
into four subregions: CA1, CA2, CA3, and CA4. The most prominent regions are the CA1 and 
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CA3, and often only these two regions are appreciated upon microscopic inspection of 
hippocampal morphology. In contrast, the dentate gyrus (DG) is composed of granule neurons. 
Hippocampal granule neurons are tiny, typically less than 10 μm in size. Moreover, hippocampal 
granule neurons undergo adult neurogenesis, while cortical and cerebellar populations of granule 
neurons do not.90 The entorhinal cortex (EC) receives input from other cortical areas and project 
axons primarily to the dentate gyrus and CA3. The subiculum (Sb) is also composed of 
pyramidal neurons and lies between CA1 and the entorhinal cortex in humans. It receives axonal 
input from CA1 and is the main output of the hippocampus with axons projecting to the nucleus 
accumbens, septal nuclei, prefrontal cortex, lateral hypothalamus, nucleus reuniens, mammillary 
nuclei, deep entorhinal cortex, and amygdala. Interspersed between these two neuron types are 
interneurons, which perform regulatory functions through the inhibition and modulation of 
neuronal firing. 
 
		
Figure 1.2. Bright field image of an OHSC and its architecture. The CA1, CA3, dentate gyrus (DG), subiculum 
(Sb), and entorhinal cortex (EC) are shown. 
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Our protocol for the preparation of OHSC follows the Stoppini method,92 whereby thin 
acute hippocampal slices are placed on a porous hydrophilic insert membrane above a medium 
containing culture nutrients. The nutrients from the medium pass through the membrane into the 
OHSC, while gas exchange occurs from above. In our laboratory, the acute hippocampal slices 
are typically obtained from postnatal rats with ages ranging from 7 to 9 day old pups. The insert 
membrane is composed of modified polytetrafluoroethylene (PTFE) and is commercially 
available (Biopore™ Millicell Organotypic Insert, Millipore, Billerica, MA). The initial thickness 
of the acute hippocampal slice is essential to prolonged viability of the OHSC, as the innermost 
cells of slices thicker than 500 μm may be susceptible to hypoxia or other forms of nutrient 
deprivation. As a result, the acute hippocampal slices used in this dissertation typically have 
initial thicknesses ranging from 300 to 500 μm to allow for adequate nutrient and gas exchange 
throughout, and are approximately 150 to 200 μm thick after 2 to 4 days of culture.93 After 
culturing for roughly two days, equilibration is achieved and the OHSC demonstrates synaptic 
rearrangement with general preservation of the in vivo circuitry. 
1.4.2 Determination of the ζ-Potential and Tortuosity 
Our laboratory has previously published a methodology to characterize the ζ-potential 
and tortuosity of OHSC.21, 22 This determination was made by observing the mobilities of 
fluorescent dyes in OHSC while an electric field is applied across the tissue. A molecule may be 
transported by electroosmosis, electrophoresis, or both in brain tissue upon application of an 
electric field with an observed velocity and mobility (vobs and μobs respectively). The observed 
mobility μobs for a single compound in a medium was provided by Equation 1.5, which includes 
μep, μeo, and λ. In this expression, the tortuosity-corrected sum of μep and μeo provided the μobs. 
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obs  vobsE 
1
2



ep eo  12 ep    1.5 
In a “two-probe” experiment, two electrophoretically and spectroscopically different fluorescent 
probes (1 and 2) were injected into a medium and μobs for each dye was measured under an 
applied electric field ranging from 3.2 to 20 V/cm.22 The observed mobilities were measured 
simultaneously during a single run and related to arrive at a value for the ζ-potential (Equation 
1.6) and λ (Equation 1.7) for the medium where the numerical subscripts referred to each of the 
two probes. 
 
obs1
ep1 ep2 
obs1 obs2 ep1






 
1.6 
  ep1 ep2obs1 obs2  1.7 
The individual ζ-potential and tortuosity values were averaged to arrive at a value for the 
OHSC. The hippocampus is grouped into heterogeneous regions with variable populations of 
cells. However, there was no significant difference for the values of tortuosity between the CA1, 
CA3, and DG regions by one-way ANOVA (p = 0.1) in the OHSC.22 The average OHSC ζ-
potential was determined to be -22.8 ± 0.8 mV and the average tortuosity was 2.24 ± 0.10 for 
70,000 MW fluorescent dextran conjugates (data presented as mean ± standard error of the 
mean).22 In comparison, the tortuosity of 70,000 MW dextran conjugates in the acute rat cortical 
slice was 2.25 ± 0.0959 and the cortex in vivo was 2.68 ± 0.11.61 
The tortuosity difference between acute slices or OHSC and in vivo conditions may be 
not only be due to the physical dispersal of OHSC cells, but also reduced osmoregulation of the 
 16 
extracellular space ex vivo, an increase in the extracellular fluid fraction, and tissue swelling that 
reduces the tortuosity. The fluid content of the extracellular space is determined by an oncotic 
pressure gradient in vivo, due to a difference in protein concentrations between the blood and 
extracellular space, as described by Starling in 1896.94, 95 In his original treatises, the net fluid 
movement between compartments, J, was related to the difference between the capillary and 
interstitial hydrostatic pressures – Pc and Pi respectively – and the vascular capillary and 
interstitial oncotic pressures – πc and πi respectively,94, 95 as shown by Equation 1.8. Two 
additional factors also enter into the equation: the filtration coefficient, Kf, and the reflection 
coefficient, σ. 
J  K f Pc Pi  c  i   1.8
The filtration coefficient describes the inherent permeability of the vascular capillary to water, 
and is a product of the capillary surface area and its permeability to water. Capillary 
permeability, and hence the filtration coefficient, varies depending on tissue type and non-
homeostatic conditions; for example, the capillaries of the kidney glomerulus have high filtration 
coefficients.96 Moreover, histamine release results in alteration of capillary bed homeostasis and 
an increase in the filtration coefficient, which results in tissue swelling.97 The reflection 
coefficient accounts for changes in capillary permeability to plasma proteins.98 If a capillary bed 
is permeable to proteins, such as albumin, the reflection coefficient is between zero and one. If 
the capillary bed has a reflection coefficient close to one, as with the kidney glomerulus, it is 
relatively impermeable to proteins.96 The human brain demonstrates a very low filtration 
coefficient of 10.4 × 10-4 cm/s and is very similar to transport by diffusion.99 Moreover, the brain 
capillary reflection coefficient also approaches one for proteins, as a result of tight junctions 
between endothelial cells.98 Therefore, the brain is relatively impermeable to fluid transport from 
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capillary beds, and as such the fluid content in the extracellular space is tightly regulated in vivo. 
Because this mechanism of osmoregulation is nonexistent in OHSC, the extracellular space is 
allowed to swell and its resulting tortuosity may be decreased from its homeostatic state in vivo. 
1.5 ELECTROOSMOTIC SAMPLING OF THE BRAIN EXTRACELLULAR SPACE 
With precise quantification of the ζ-potential and tortuosity, our lab has been able to transport 
molecules in the extracellular space of OHSC using electroosmosis. In particular, this work has 
focused on the minimally invasive uptake of nanoliter volumes of extracellular fluid for the 
sampling and determination of peptide concentrations and ectopeptidase activity with high 
spatial resolution in the OHSC.100 
In these initial sampling experiments,100 the OHSC and its insert membrane were placed 
in an optically transparent dish with an artificial cerebrospinal fluid solution containing the 
peptide of interest underneath. A 150 μm inner diameter fused silica capillary was inserted into 
the CA3 region of the OHSC with its distal end immersed in a second dish with the artificial 
cerebrospinal fluid solution; the capillary was filled with the same solution to make electrical 
contact between the two dishes. A platinum electrode was placed in each dish. When an electric 
field was applied across the two electrodes, electroosmosis the fluid beneath the OHSC insert 
membrane was conveyed into the OHSC where an ectopeptidase acts on its peptide substrate, 
with further conveyance of this extracellular fluid into the sampling capillary and towards the 
second dish. Diluted samples were obtained and passed through a capillary HPLC with 
electrochemical detection of the relevant peptides. The sampling process required only a few 
minutes with electric fields ranging from 30 to 60 V/cm at the capillary tip. The electric fields at 
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the capillary tip utilized in electroosmotic sampling were significantly larger than the fields used 
across the OHSC in the determination of the ζ-potential and tortuosity values by the two-probe 
method. This naturally begs the question: does this methodology damage, or even kill, cells in 
the OHSC? 
In a second follow-up paper from our group, Hamsher et al. demonstrated the 
electroosmotic sampling conditions necessary to minimize damage to the OHSC.101 To assess 
OHSC viability, propidium iodide was co-incubated with the tissues for up to one day before 
electroosmotic sampling. Propidium iodide is a salt that is soluble in physiological buffer 
solutions, such as artificial cerebrospinal fluid. Because of its charge, it is unable to appreciably 
pass through the cell membranes by diffusion. However, when a cell is damaged, propidium 
intercalates DNA and forms a strongly fluorescent complex. Thus, propidium iodide is an 
indirect marker of cell death. As described in this paper, “safe” sampling conditions were taken 
as less than 10% of the fluorescence of a positive methanol-stained control after correction for 
the negative control.101 
A wide array of experimental parameters was evaluated, including the region of the 
OHSC sampled from, the depth of capillary insertion into the OHSC (or distance of the capillary 
tip away from the tissue surface itself), the inner diameter of the capillary, and the applied 
voltage. For electroosmotic sampling with lower than 1,300 V, the average propidium 
fluorescence (± standard error of the mean) increased only 1.0 ± 0.3 % and there was no 
difference between the CA1 and CA3 regions (p > 0.08).101 At conditions greater than 1,400 V, 
CA1 was more vulnerable than CA3 (p < 0.007).101 The observed fluorescence increases, and by 
extension tissue damage, were seen at the sampling site and not at remote areas of the OHSC. 
Capillaries of 150 μm inner diameter resulted in less tissue damage (≤ 10% propidium 
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fluorescence increase) across all tested voltages (≤ 2,000 V), while larger 280 μm inner diameter 
capillaries demonstrated an approximately 20 to 25 % propidium fluorescence intensity increase 
at more than 900 V.101 As a general rule, when the power dissipated in the OHSC was less than 
120 μW, the cell death was less than 10% of the positive control as measured by propidium 
fluorescence. To calculate the power dissipated, the resistance of OHSC was estimated as 40% of 
the resistance of the electrolyte buffer solution, as the extracellular volume fraction in OHSC 
was approximated as 40%.101 
In summary, these two papers described the methodology for electroosmotic sampling 
and parameters whereby it could be applied to OHSC with minimal damage.100, 101 Our lab has 
demonstrated the utility of electroosmotic uptake of peptides for analysis. However, the focus of 
this dissertation utilizes electroosmosis to deliver compounds over short distances, with relevant 
discussion to capillary iontophoresis, and longer distances, as applied to the clinical treatment of 
malignant brain tumors and convection-enhanced delivery. 
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2.0  SYNTHESIS AND CHARACTERIZATION OF A GEL MODEL WITH THE 
ELECTROKINETIC PROPERTIES OF ORGANOTYPIC HIPPOCAMPAL SLICE 
CULTURES 
2.1 INTRODUCTION 
When an electric field is applied across an electrolyte-filled, porous matrix electrophoresis and 
electroosmosis occur. This electrokinetic transport depends on key properties of the matrix and 
solutes. Electrophoresis is the movement of a charged solute under the influence of an applied 
electric field, traditionally used for separation and analysis. In contrast, electroosmosis is the 
bulk fluid flow that is stimulated when an electric field is applied to an electrolyte solution in a 
porous matrix with a non-zero ζ-potential. In other words, electroosmosis is the movement of the 
solvent, while electrophoresis is the movement of the solute in an applied electric field. The 
electroosmotic velocity is proportional to the ζ-potential that exists at the boundary between the 
fluid in the porous space and the stationary walls that contain the fluid. For example, fixed 
charges on cell-surface functional groups and membrane-bound constituents of the extracellular 
matrix create a ζ-potential.21 The electroosmotic velocity of a neutral solute molecule – the 
direction and distance traveled under an applied electric field in a given time – in a particular 
medium is thus governed by the ζ-potential of that medium, and the direction and magnitude of 
the electric field. This relationship is described by the Helmholtz-Smoluchowski equation as 
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shown in Equation 2.1, where veo is the electroosmotic velocity, η is the viscosity of the medium, 
ε is the permittivity of the fluid, ζ is the ζ-potential, μeo is the electroosmotic mobility, and E is 
the applied electric field. 
vobs  veo   E  eoE  2.1 
Poly(acrylamide)-based hydrogels applied to separations were first developed over fifty 
years ago, and their utility was explored for separation of proteins, DNA, and other 
macromolecules.102-105 One reason for the wide acceptance of poly(acrylamide) over other 
matrices used for electrophoresis is the lack of significant electroosmotic flow, and thus a ζ-
potential. Interestingly and in contrast, there has been considerable work in recent years for the 
development of separations matrices that provide electroomosis to separate both neutral and 
charged molecules.106-111 For example, Fujimoto et al. introduced negatively charged sulfonate 
moieties into an acrylamide-based hydrogel to increase separation of neutral molecules under 
physiological pH.110 Anionic gellan gels can be crosslinked by Ca2+, but the resulting gel is not 
neutral. The additive poly(ethylene oxide) reduces electroosmotic flow in these gellan gels to aid 
with electrophoretic separation.108 Negatively charged polyacrylamide-based matrices have also 
been synthetically prepared for capillary electrochromatography.110, 112 Acrylates have also been 
used as the organic component in organic-silica hybrid monolithic capillary columns.111-113 
Multilayered polyelectrolytes incorporating acrylic acid have been developed for control of 
electroosmotic flow in capillaries and microfluidic channels. By suitable control of the surface 
modification chemistry, a range of electroosmotic mobilities can be obtained at pH 7.4 (or other 
values).114 Thus, the development and fine control over electroosmotic flow in polymeric gels, 
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and in channels with walls of multilayered polyelectrolytes, have been of long-standing interest 
and practical importance. 
Diffusion also plays a role in molecular transport. It is related to the rate of net transport 
of a molecule along a chemical potential gradient. Rates of diffusion depend on temperature, the 
viscosity of the medium, the magnitude of the chemical potential gradient, and the size of the 
moving molecules. In a medium such as a hydrogel or tissue in which there are obstructions, the 
diffusion rate is lower than it would be in an unobstructed medium. The presence of obstructions 
gives rise to tortuosity. The tortuosity of a medium can be determined as a ratio of the diffusion 
coefficients for a molecule in free solution to a molecule in the tortuous medium (i.e.: the matrix 
of interest), as given by Equation 2.2 where λ is the tortuosity, D is the diffusion coefficient in 
free solution, and D* is the diffusion coefficient in the medium of interest.59 
  D
D*
 
2.2 
The diffusion coefficient in the medium, and thus the tortuosity, depends upon the three-
dimensional structure of the hydrogel matrix, the solute size and shape, and any frictional or 
viscous drag forces the solute experiences in the matrix.31 
Translational motion of molecules in the extracellular space of biological tissues is 
typically viewed as occurring by diffusion and tortuosity.28 Electroosmotic flow represents an 
additional transport mechanism that occurs in tissues due to natural processes, such as neuronal 
depolarization1, 19 or due to applied electric fields.23, 115-120 We have previously measured the ζ-
potential and tortuosity of organotypic hippocampal slice cultures (OHSC) as a representative for 
living brain tissue. The ζ-potential of OHSC is -22.8 ± 0.8 mV and the tortuosity is 2.24 ± 0.10.22 
The ζ-potential of skin pores is also important, as electroosmosis is a fundamental component of 
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transdermal iontophoresis.121 While electroosmotic transport in skin has been investigated for 
many years, the understanding that the ζ-potential in brain is significant is recent. We have 
demonstrated the application of electroosmosis in OHSC for drawing peptides through the 
OHSC, followed by analysis of the captured sample to infer peptidase activity in the extracellular 
space.100 However, in this work, or any related attempt to use electroosmosis in brain, it is 
necessary to assess the degree to which electroosmosis contributes to solute transport. 
Unfortunately, it is impossible to control the ζ-potential in the extracellular space of a living 
tissue, as the ζ-potential is intrinsically tied to the physical composition of the tissue. 
As such, we developed poly(acrylamide-co-acrylic acid) hydrogels with a range of ζ-
potentials and tortuosities. At physiological pH, the acrylic acid exists as the negatively charged 
acrylate species. These fixed anions create a ζ-potential in the gel polymer matrix. Three 
hydrogels were prepared with 0, 10, and 25% (w/w) acrylic acid. These three types of hydrogel 
had distinctly different ζ-potentials and degrees of electroosmosis, with the highest acrylate 
content hydrogel demonstrating a ζ-potential comparable to the OHSC. This work describes the 
synthetic preparation of the three hydrogel compositions, as well as the determination of their ζ-
potentials and tortuosities. The result is a set of gels with well-known ζ-potentials and 
tortuosities. 
2.2 EXPERIMENTAL 
2.2.1 Chemicals 
All reagents used to make the poly(acrylamide-co-acrylic acid) hydrogels were purchased 
 24 
from Aldrich (St. Louis, MO) and were used without additional purification. Fluorescent dyes – 
Texas Red dextran conjugate 70 kDa (TR70), fluorescein dextran conjugate 70 kDa (FL70), and 
Texas Red dextran conjugate 3kDa (TR3) – were purchased from Invitrogen/Molecular Probes 
(Eugene, OR). 
2.2.2 Standard Solution Preparations 
A glucose-free HEPES-buffered salt solution (GF-HBSS) containing (mM): 143.4 NaCl, 
5 HEPES, 5.4 KCl, 1.2 MgSO4, 1.2 NaH2PO4, and 2.0 CaCl2. GF-HBSS was prepared with 18 
MΩ purified water from a Millipore Synthesis A10 system (Millipore, Billerica, MA), filtered, 
adjusted to pH 7.40, and refrigerated at 2.6 °C. It was warmed to 37 °C before use. TR70 and 
FL70 were dissolved in GF-HBSS to make 0.34 mM and 0.67 mM solutions, respectively, then 
filtered with 13 mm, 0.45 µm nylon filter units or equivalents (Millipore) and frozen until use. 
Before use, dextran conjugates were modestly diluted with GF-HBSS to final concentrations of 
0.19 mM for TR70, 0.29 mM for FL70, and 0.40 mM for TR3. 
2.2.3 Synthesis of Hydrogels 
Poly(acrylamide-co-acrylic acid) hydrogels were prepared by a thermally-initiated radical 
polymerization reaction. The total weight of reagents was kept constant (279 mg/5 mL) while the 
component w/w ratios of acrylic acid and acrylamide were varied, as described in Table 2.1. The 
gels had an acrylic acid percentage of 25%, 10%, and 0% (weight of acrylic acid/weight of all 
monomer species). The bisacrylamide cross-linker was maintained at a fixed weight percentage 
of approximately 1.4%. Early efforts to weigh this small amount of cross-linker with a standard 
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electronic balance (Mettler-Toledo, Columbus, OH, Model AG245; readability 0.1 mg) resulted 
in somewhat variable gel parameters, In later experiments, the cross-linker was more accurately 
weighed (Mettler-Toledo, Columbus, OH, Model XS105DU; readability 0.01 mg) with 
variability less than 0.1 mg. This is described further in the results and discussion section. 
 
Table 2.1. Table of reagents for each synthetic gel type. 
 25% Acrylic Acid 10% Acrylic Acid 0% Acrylic Acid 
weight (mg) mmol weight (mg) mmol weight (mg) mmol 
Acrylamide 206.0 2.90 247.5 3.48 275.0 3.87 
Acrylic Acid 69.0 0.96 27.5 0.38 0.0 0.00 
Bisacrylamide 4.0 0.03 4.0 0.03 4.0 0.03 
 
The reagents were weighed and dissolved in 4.5 mL of ultrapure water (Cayman 
Chemical, Ann Arbor, MI) each and stirred vigorously for 5 minutes. The solutions were then 
titrated to a pH range of 7 to 8 using an aqueous 1 M NaOH solution. The final solution volumes 
were brought to 5.0 mL with ultrapure water. The three solutions were then deaerated with 
nitrogen for 20 minutes at room temperature. Immediately after deaerating, 5.0 mg of ammonium 
persulfate (0.02 mmol) and 5.2 μL of tetramethylethylenediamine (TEMED, 0.03 mmol) were 
quickly added to each solution, which was vigorously stirred for another 3 minutes at room 
temperature. Each clear solution was poured in a 50 mm x 16 mm Pyrex glass dishes and placed 
inside an oven at 100 ±	5 °C for 2 hours. The Pyrex dishes were removed from the oven and 
allowed to cool for 10 minutes at room temperature. The clear, colorless gels were separated 
from the Pyrex dish walls and slowly peeled from the dish. Each gel was individually placed in a 
covered plastic dish filled with approximately 25 mL GF-HBSS solution and shaken lightly at 10 
°C overnight. The buffer solution was exchanged the following day with 25 mL of fresh GF-
HBSS, placed back in the shaker at 10 °C for another 24 hours. Finally, the GF-HBSS was 
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exchanged once more (25 mL), and the gels were placed in the refrigerator where they were 
allowed to complete the equilibration. A final pH check was performed to assure the gels were 
pH 7.40 with full immersion of the probe into the gel before further characterization 
2.2.4 Characterization of the ζ-Potential and Tortuosity 
The experimental apparatus was used without modification from our previously reported 
setup.22 A four-electrode potentiostat coupled with a differential amplifier and reference Luggin 
capillary electrodes was used to provide feedback control of the electric field in the gel. GF-
HBSS was used as the electrolyte solution in the reservoirs. Imaging of the experiment was done 
with an Olympus IX-71 inverted fluorescence microscope with an Olympus UPlan Apo 4× 
objective lens (Melville, NY), and a charge-coupled device camera (ORCA-285 Hamamatsu, 
Hamamatsu City, Japan). A DA/Fl/TA-3X-A triple-band “Pinkel” filter set (Semrock, Rochester, 
NY), with exciter 1 at 387 nm, exciter 2 at 494 nm, exciter 3 at 575 nm, triple-band dichroic 
mirror: 394-414 nm, 484-504 nm, 566-586 nm, emitter: 457, 530, 628 nm were used according 
to the fluorescent properties of the molecules. SimplePCI 6.0 software (Compix, Cranberry, PA) 
was used for image acquisition and processing. 
 Prior to the start of the ζ-potential measurements, the gel was injected with each 
fluorophore solution separately to set exposure times for each fluorophore. A fresh piece of gel 
was cut to size and placed in the apparatus channel over the objective lens. Using a P-2000 
capillary puller from Sutter (Novato, CA), a 150 μm inner diameter (ID) fused silica capillary 
was pulled to a tip opening of approximately 12 μm to create an injection capillary. The injection 
capillary was filled with the TR70/FL70 or TR3 fluorophore solution and lowered 
perpendicularly into the gel using a MP-285 micromanipulator (Sutter, Novato, CA) to a depth of 
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half the gel’s thickness. The distal end of the injection capillary was connected to the FemtoJet® 
express (Hamburg, Germany), pressurized via a compression nitrogen tank from Valley Natural 
Gas (Wheeling, WV). The FemtoJet® express was set to deliver an injection pressure of 200 to 
250 hPa for 0.2 to 0.5 seconds, with a compensation pressure of 0 to 20 hPa. The exact 
parameters were varied within these ranges so that the volume of ejected fluorophore was 
appropriate for the sensitivity and dynamic range of the CCD camera. Once the injection was 
complete, the injection capillary was raised from the OHSC and moved aside. The Luggin 
capillaries were lowered to a depth of half the gel’s thickness on either side of the injection spot. 
This process was completed an average of two times per gel piece, and all experiments were 
conducted at ambient temperature (24 to 26 °C). 
An electric field between 60 and 250 V/m was applied to each gel. One image was 
acquired every second. The electric field was monitored at the two Luggin capillaries and at the 
platinum electrodes in the reservoirs by two multimeters to ensure accurate control of the electric 
field. Movement of a fluorophore towards the cathode was defined as positive movement. The 
velocities of the TR70 and FL70 fluorophores were measured post-analysis using Simple PCI. 
Specifically, the velocity was measured as the distance that the fluorophore moves over a period 
of time. The locations of the fluorophores were defined by their maximum peak intensities at 
time zero and at one other time during the experimental run. Typically, 6 to 9 timepoints (30 to 
60 seconds apart) were analyzed per run to arrive at an average velocity. The ζ-potential and 
tortuosity for each gel were extracted with this analysis, as previously described.22 
2.2.5 Measurement of Solute Diffusion Coefficients in the Hydrogels 
Prior to the start of the diffusion measurements, a characterized 25% and 0% acrylic acid 
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gel were independently injected with a TR70 or TR3 fluorophore solution to set each exposure 
time. The fused silica injection capillaries used were the same as previously described. The 
injection capillary was filled with the fluorophore solution and lowered perpendicularly into the 
gel using a micromanipulator to a depth of half the gel’s thickness. The injection capillary was 
connected to the FemtoJet® express set to deliver an injection with the same parameters as 
described previously. Following ejection, the injection capillary was immediately withdrawn by 
the micromanipulator and moved aside. After each ejection, an image was taken every 2 to 5 
seconds for a total duration of 3 to 6 minutes to record the diffusion of the fluorophore. All 
experiments were conducted at ambient temperature (24 to 26 °C). This was repeated for each 
gel and fluorophore type. Imaging of the experiment was done with the fluorescence microscope 
as described earlier, and SimplePCI 6.0 software was used for image acquisition and processing. 
 Following acquisition, the images at 10 second time intervals were exported as an (x,y)-
matrix of fluorescence intensities. These data matrices were imported into OriginPro 8.1 
software (OriginLab, Northampton, MA). A three-dimensional Gaussian surface was fit to the 
data set in order to find the peak. The image was then cropped three standard deviations from the 
peak’s center in the x- and y-directions. With this reduced data set, a second Gaussian fit was 
performed yielding the standard deviations of the Gaussian fit in both the x- and y-directions. 
The standard deviations in the x- and y-directions were very similar and consistent with the 
Gaussian fit. The variance was obtained by squaring the average of the two standard deviations. 
The variance was plotted against time and a linear regression was performed. If a line fit had an 
R2 value less than 0.95, it was not included in the final average. As with work by Nicholson et 
al., dividing the slope of this line by four afforded the diffusion coefficient.59 Averaging the 
diffusion coefficients from each run (typically 3 to 6 runs per gel) allowed determination of a 
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final diffusion coefficient with standard error. 
2.2.6 Free Diffusion Coefficients of Dextran Conjugates 
Free diffusion coefficients were determined as described by Beisler et al.122 GF-HBSS 
mobile phase pumped through the system using a Pico Plus syringe pump (Harvard Apparatus, 
Holliston, MA). The sample solutions were injected using an HP 1050 autosampler (Hewlett-
Packard, Palo Alto, CA) into a 1.0 μL loop in a VICI 6-port Cheminert Injector (Houston, TX). 
An ISCO 3850 Capillary Electropherograph UV detecctor (Teledyne ISCO, Lincoln, NE) was 
used for detection (215 nm) of the fluorophores. Signals were collected by Peaksimple 3.29 
software (SRI Inc., Torrance, CA) for analysis. The data were imported into OriginPro for 
differentiation, followed by the determination of the first and second central moments using 
PeakFit 4.0 software (Systac Software Inc., San Jose, CA). Diffusion coefficients were 
calculated from the slopes of second moment versus first moment linear plots. In addition, errors 
for the diffusion coefficients were calculated based on the error of the slope, assuming negligible 
error in the flow rate, capillary length, and capillary diameter. 
2.2.7 Characterization of the Hydrogel Water Content 
The water content of each gel was determined by dehydration weighing. A 10 mm by 10 
mm piece of gel was cut and placed inside of a pre-weighed 1.8 mL ROBO autosampler vial 
(VWR, West Chester, PA). The aggregate weights were recorded for each vial, and they were 
placed in an oven at 110 °C overnight. The vials were removed from the oven and reweighed. 
The water content, by weight, was determined by subtracting the post-dehydration weight from 
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the pre-dehydration weight, controlling for the autosampler vial weight and residual salt content 
within the GF-HBSS buffer. Six runs were completed for each gel type, with the final water 
content data provided as an average with standard error. 
2.2.8 Statistics 
All data are presented as mean ± standard error of the mean (SEM), where N represents 
the number of experimental runs. Comparisons among groups were made by one-way analysis of 
variance (ANOVA) with p < 0.05 considered as significant. 
2.3 RESULTS AND DISCUSSION 
As demonstrated in Figure 2.1, while under a constant electric field, in the 0% acrylic acid gel 
composition there was significant movement of the anionic FL70 dextran conjugate 
(electrophoretic mobility -8.80 ± 0.2 ×10-9 m2/Vs, N = 3)21 towards the cathode and negligible 
movement of the weakly cationic TR70 dextran conjugate (electrophoretic mobility 0.46 ± 0.03 
×10-9 m2/Vs, N = 3, slightly different from published value due to commercial batch),21 The 10% 
acrylic acid gel composition showed movement of the TR70 dextran conjugate towards the 
anode and negligible movement of the FL70 dextran conjugate, while the 25% acrylic acid gel 
composition showed movement of both the FL70 and TR70 dextran conjugates towards the 
anode. These results indicate qualitatively that as the percentage of acrylic acid increases, the ζ-
potential becomes more negative, and there is an increasing contribution of electroosmosis to the 
observed field-induced velocity. 
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Figure 2.1. Electrokinetic transport in the three hydrogels. TR70 (red) and FL70 (green) dextran conjugates move 
differently under a uniformly applied electric field in the poly(acrylamide-co-acrylic acid) gels prepared at 0%, 10%, 
and 25% w/w acrylic acid. 
 
The magnitudes of the ζ-potential and tortuosity were determined for each hydrogel, as 
displayed in Table 2.2. Of note, the ζ-potential was consistent within each set of gels with the 
same nominal composition, with a linear correlation describing the w/w percentage of acrylic 
acid and the ζ-potential. One-way ANOVA analysis for the effect of composition (percent 
acrylic acid) on ζ-potential shows that the effect was significant (p < 0.001). Furthermore, as a 
general trend, for every 1% increase in acrylic acid added to reaction mixture, the ζ-potential 
changed by -0.9 mV, as shown in Figure 2.2. Regression of all ζ-potential values versus 
percentage of acrylic acid yielded a correlation that was highly significant (R2 = 0.91, p < 0.001). 
Moreover, the 25% acrylic acid gel composition demonstrated a ζ-potential similar to the OHSC. 
 32 
 
Figure 2.2. Summary of the ζ-potential of each hydrogel as a function of the w/w% acrylic acid. Linear regression 
fit, R2 = 0.91. 
 
To determine the mass of water within the hydrogels, a series of dehydration experiments 
was performed, the results of which are shown in Table 2.3. The 25% acrylic acid gel 
composition had a larger percentage of water than the gels with lower w/w percentages of acrylic 
acid, with one-way ANOVA revealing a significant difference among the gel types (p < 0.001). 
The fluid content was correlated with the percentage of acrylic acid (R2 = 0.73, p < 0.001). This 
was consistent with the observation that there was greater swelling in gels containing more 
acrylate as the negative charges attracted counterions with a concomitant fluid influx.123 It is for 
this reason that careful equilibration of the gels in HBSS was conducted following synthesis and 
prior to characterization, with all experimentation utilizing careful control of the pH. 
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Table 2.2. Summary of ζ-potentials and tortuosities determined by the electrokinetic method.	
Gel Type Gel Code ζ-Potential 
(mV) 
Tortuosity 
(λ) 
Replicates 
(N) 
Average ζ-
Potential (mV) 
Average 
Tortuosity (λ) 
0% 
0A -0.3 ± 0.04 1.69 ± 0.16 4 -1.3 ± 0.5§ 
(N = 16) 
2.28 ± 0.13§ 
(N = 16) 0B -1.6 ± 1.1 2.56 ± 0.16 6 0C -1.9 ± 0.6 2.39 ± 0.18 6 
10% 
10A -13.1 ± 0.3 2.21 ± 0.12 6 -12.8 ± 0.7§ 
(N = 15) 
1.80 ± 0.10§ 
(N = 15) 10B -15.2 ± 0.8 1.46 ± 0.07 5 10C -9.5 ± 0.2 1.61 ± 0.08 4 
25% 
25A -27.9 ± 0.4 1.39 ± 0.03 6 -24.9 ± 0.9§ 
(N = 21) 
1.44 ± 0.09§ 
(N = 21) 25B -22.1 ± 0.6 1.07 ± 0.03 6 25C -24.7 ± 1.7 1.71 ± 0.18 9 
25%* 25* -23.0 ± 0.3 2.36 ± 0.18 4 Not Included 
*Note: the pH for this 25% gel was not adjusted to pH 7-8 before radical polymerization, and is not included in 
statistical calculations or comparisons. 
§Note: Groups are statistically different by one-way ANOVA (p < 0.05). 
 
The tortuosities for the 70,000 MW fluorescent dextran conjugates as determined by 
application of an electric field within each gel type are shown in Table 2.2. One-way ANOVA 
demonstrated a significant effect of composition on tortuosity (p < 0.001). Additionally, the 
tortuosity of each gel measurement was significantly correlated with the percentage of acrylic 
acid added during synthesis (R2 = 0.24, p < 0.0002). Even though there was a significant 
difference between gel types, there was also a range of tortuosity values within each gel type. 
This range may be due to minor variability in gel synthesis as a result of imprecise weighing of 
reagents, measurement error in determining the observed velocity of dextran conjugates in the 
applied electric field, heterogeneity of the gel matrix itself, and to a much lesser extent, affinity 
of a molecule for the gel matrix and shrinking or swelling of a gel in response to an applied 
electric field.124-130 Shrinking and/or swelling may result from local pH changes and the 
movement of counterions once an external electric field is applied. This local physical distortion 
may alter the tortuosity from its equilibrium state in the absence of an applied electric field. 
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Typically, gels that demonstrate this phenomenon involve higher concentrations of acrylic acid 
and lower cross-linker concentrations.128 
Table 2.3. Summary of water content in the various gel types. 
Gel Type Gel Code Percentage of Water in Gel Number of Runs (N) 
25% 25C 98.3 ± 0.1 % 6 
10% 10C 97.5 ± 0.3 % 6 
0% 0C 96.6 ± 0.1 % 6 
 
To determine whether there is an effect of electric field-inducing shrinking or swelling, 
the tortuosity in the absence of an electric field in the 25% acrylic acid gel (which is most 
susceptible to the electric field) was determined. From Equation 2.2, the tortuosity of a system 
without application of an electric field is obtained by merely observing the diffusion of a 
fluorescent molecule of interest in the gel, yielding D*. To arrive at a value for D, we performed 
Taylor dispersion measurements of the fluorescent dextran conjugates. The results for these 
experiments are shown in Table 2.4. The resulting diffusion coefficient-based tortuosities for the 
70,000 MW TR70 dextran conjugate in the 25% acrylic acid gel (Gel Code 25C) were compared 
to the tortuosities obtained electrokinetically. The two tortuosities were not significantly different 
(p = 0.39). Unlike the 25% acrylic acid gels, the 0% acrylic acid gel should be immune to 
electric field effects. Thus, as a test of this assumption, D* for TR70 was also measured in a 0% 
acrylic acid gel (Gel Code 0C). Again, the resulting diffusion coefficient-based tortuosity was 
not significantly different from the tortuosity obtained from application of an electric field using 
ANOVA (p = 0.87). Each of the high and low ζ-potential gel types has a tortuosity that was 
independent of the characterization method. If electric field-induced swelling or shrinking 
occurred to a large extent, the two tortuosity measurements would be different in the 25% acrylic 
acid hydrogels, but not the 0% acrylic acid hydrogels. This was not the case, and therefore the 
effect of swelling or shrinking of our gels in an electric field was not appreciable. 
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Table 2.4. Summary of TR70 and TR3 Diffusion Coefficients and Tortuosities in 25% and 0% Acrylic Acid Gels. 
 
Observed 
Diffusion 
Coefficient (D*) 
(10-7 cm2/s) 
25% Gel (25C) 
Observed 
Diffusion 
Coefficient (D*) 
(10-7 cm2/s) 
0% Gel (0C)
Free Diffusion 
Coefficient 
(D) 
(10-7 cm2/s) 
Free D (CE)
Tortuosity 
25% Gel 
Tortuosity 
0% Gel 
TR70 0.94 ± 0.09 
(N = 3) 
0.62 ± 0.05 
(N = 3) 
3.66 ± 0.16 
(N = 32) 
1.97 ± 0.20 2.43 ± 0.11 
TR30 10.12 ± 1.19 
(N = 5) 
8.44 ± 0.51 
(N = 4) 
10.48 ± 0.48 
(N = 48) 
1.02 ± 0.06 1.11 ± 0.04 
 
The tortuosity, as measured according to Equation 2.2, is to a degree dependent on the 
hydrodynamic radius of the solute, and by extension its molecular weight.21, 45, 131 We determined 
D* of the smaller TR3 in the same hydrogels and D by Taylor dispersion measurements, with 
results also shown in Table 2.4. As expected, TR3 demonstrated faster diffusion than TR70 in 
the hydrogels. The tortuosities of the gels as perceived by the solute TR3 in the 25% and 0% 
acrylic acid gels were 1.02 ± 0.06 and 1.11 ± 0.04 respectively. These values approached unity 
and reflect that the diffusion of smaller molecules was relatively unhindered compared to larger 
molecules. 
Other potential sources of error in tortuosity measurement include affinity-type 
interactions of the fluorophore with the hydrogel matrix and error in determining the diffusion 
coefficients themselves. Affinity-type interactions are observed in gel electrophoresis 
applications between the gel matrix and ligand, including with proteins, DNA, and small 
molecules.132-134 An affinity-type interaction would result in a slower observed velocity when an 
electric field is applied, and thus alter both the tortuosity (as measured by electrokinetic or 
diffusional characterization methods) and ζ-potential measurements. However, our Texas Red 
dextran conjugates are commercial products that demonstrate very low affinity for biological 
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extracellular matrices and similarly charged components.21 Finally, the method of determining 
diffusion coefficients described in this work was susceptible to error also. The largest source of 
error was probably the shape of the initial spot of fluorophore. An extended spot will lead to a 
non-Gaussian profile at short times. This may become almost Gaussian with time, of course. It 
was for this reason that we rejected experiments in which the fit to the two-dimensional Gaussian 
curve was poor (R2 < 0.95). Retrospective analysis of these omitted runs demonstrated abnormal 
fluorophore injections and pressure-induced deformation of the gel matrix.  
Aside from measurement errors, there may be gel-to-gel differences among gels of the 
same nominal composition. For example, differences within a gel type may perhaps arise from 
the accuracy of weighing small amounts of the bisacrylamide cross-linker used in the hydrogel 
synthesis. Altering the bisacrylamide cross-linker concentration (and also the total acrylamide 
concentrations) was shown to alter dramatically the apparent gel pore size and relative mobilities 
of small nucleic acids.135 To determine whether the accuracy of the weight of crosslinker was 
responsible for some of the variability, the bisacrylamide was more accurately weighed (see 
section 2.2.2) to prepare a series of three 10% acrylic acid gels (Gel Codes 10D,E,F) for 
comparison to the other 10% acrylic acid gels presented in Table 2.2. The diffusion coefficient 
(D*) of TR70 was then characterized in each of these gels, with data shown in Table 2.5. The 
average tortuosity for the three gels is 1.62 ± 0.08 (N = 13). This can be compared to the 
electrokinetically determined tortuosity value of 1.80 ± 0.10 (N = 15) in Table 2.2. While the two 
methods yielded statistically indistinguishable tortuosity results (p = 0.19), accurate weighing of 
the bisacrylamide cross-linker reduced the variability of the tortuosity results (variance reduced 
to 0.07 from 0.16). As such, tortuosity may be better controlled by using a more consistent 
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bisacrylamide cross-linker concentration. Of note, higher cross-linker concentrations resulted in 
brittle and opaque hydrogels. 
 
Table 2.5. Summary of TR70 Diffusion Coefficients and Tortuosity in 10% Acrylic Acid Gel with 4.0 ± 0.1 mg 
bisacrylamide. 
 
10% Gel 
Code 
Observed Diffusion Coefficient 
(D*) 
(10-7 cm2/s) 
Free Diffusion Coefficient 
(D) 
(10-7 cm2/s) 
Tortuosity 
10D 1.07 ± 0.11 (N = 4) 
3.66 ± 0.16 
(N = 32) 
1.85 ± 0.10 
10E 2.10 ± 0.10 (N = 5) 1.32 ± 0.04 
10F 1.22 ± 0.07 (N = 4) 1.73 ± 0.06 
 
2.4 CONCLUSIONS 
Ultimately, poly(acrylamide-co-acrylic acid) hydrogels were relatively easy to produce and may 
represent a useful matrix for analytical or preparative separations and a synthetic surrogate for 
biological tissue to understand tissue-related electrokinetic phenomena in a simpler, more 
controllable environment than tissue itself. The ζ-potential of these gels in physiological buffer 
was, remarkably, nearly directly proportional to the percentage of acrylic acid used in the 
hydrogel synthesis. As a result, we were able to mimic the electrokinetic properties of brain 
tissue, as well as removing the ζ-potential from the matrix. This capability will allow for 
quantitative determination of the degree to which the ζ-potential contributes to solute transport in 
brain tissue in an electric field. Moreover, the tortuosities of the hydrogels were determined by 
application of an electric field and by measurement of field-free diffusion coefficients, with the 
two methods yielding statistically indistinguishable results. While the tortuosities were different 
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amongst gel types, there was significant variability within each gel type. This variability was 
probably due to a slight inconsistency between syntheses. It is noteworthy that there is also a 
considerable difference between the tortuosity of acute rat cortical slices (2.25 ± 0.09)59 and the 
tortuosity of rat cortex in vivo (2.68 ± 0.11)61 by measurement of diffusion coefficients. Clearly, 
the tortuosity of ‘soft’ matter is highly dependent on conditions. 
The ζ-potential, tortuosity, and equilibrium fluid content of the hydrogels were all 
correlated with the percentage of acrylic acid added during synthesis. This was inconvenient 
from the perspective of determining the relative importance of the ζ-potential and tortuosity on 
molecular transport because a change in the acrylate percentage changes both the ζ-potential and 
tortuosity. However, this correlation is expected. The higher the acrylic acid content, the more 
swelling is expected – that is, the equilibrium water content is higher. The higher water content 
leads to a more dilute gel with a larger spacing between polymer chains and thus a lower 
tortuosity. This internal consistency suggests that the gels studied were at equilibrium, and thus 
that the results were equilibrium properties of the gels. Moreover, the tortuosities derived from 
electrokinetic and two-dimensional diffusion coefficient methods were not significantly 
different. This is the first report in which tortuosity of a material was determined both 
electrokinetically and by diffusion. This is also, to our knowledge, the first report of the 
determination of the ζ-potential and tortuosity of hydrogels with correlation of these 
electrokinetic transport properties with synthetic procedure. Besides representing a synthetic 
tissue surrogate, the ability to control the gel’s properties may afford further utility in the fields 
of separations, biomaterials, and polymer science. 
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3.0  SHORT-DISTANCE ELECTROKINETIC INFUSION OF MACROMOLECULES 
AND SMALL MOLECULES IN A GEL MODEL AND ORGANOTYPIC 
HIPPOCAMPAL SLICE CULTURES 
3.1 INTRODUCTION 
Our laboratory has demonstrated the utility of electroosmosis for the sampling of extracellular 
fluid from OHSC.100 However, it is also theoretically possible to deliver molecules into the 
extracellular fluid. As discussed previously, this electrokinetic delivery also utilizes the 
electrophoretic and electroosmotic mobilities of the molecules, the properties of the matrix being 
ejected into (including the ζ-potential, viscosity, and permittivity), and the applied electric field. 
The poly(acrylamide-co-acrylic acid) hydrogels developed in the previous chapter provide a 
robust model system to control the degree of electroosmosis that may occur during delivery into 
a matrix of interest. In fact, localized ejections of molecules have already been implemented in 
neuroscience research using iontophoresis, though a widespread misconception regarding the 
mechanism of ejection seems to exist amongst neuroscientists.136-139 
Iontophoresis includes the movement of ions into biological tissue resulting from the 
conveyance of an electric current through a solution in contact with that tissue. It is a method of 
localized delivery that utilizes an electrical current to circumvent the blood-brain barrier,117 and 
has even been used to deliver compounds to the brain through the nasal mucosa.118 Capillary 
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iontophoresis is used to locally stimulate neuronal pathways by ejections from tiny micrometer 
sized borosilicate capillary tips to understand neuronal physiology. Traditionally, these ejections 
utilize low currents (≤ 100 nA) and pulsed millisecond ejection times. In contrast, iontophoresis 
has been used to deliver solutes outside of the brain by transdermal, transocular,140, 141 and 
transurethral routes.142 Initial experiments by Sir Henry Barcroft and colleagues in 1943 applied 
epinephrine by ‘iontophoresis.’143 This technique involved wrapping epinephrine-soaked 
bandages around the arm to determine causes of forearm blood flow variability following nerve 
blockage. Current transdermal methods traditionally use a pad as a source for solutes being 
transported into the tissue rather than a capillary. In fact, much of the understanding of 
electroosmosis in biological systems derives from transdermal iontophoresis, including a well-
established appreciation of electroosmosis within the skin pores. Skin has an appreciable ζ-
potential within pores and a low ζ-potential elsewhere.121 However, placement of a pad to 
perform iontophoresis is only applicable to a target tissue near the surface or deeper tissue 
exposed through surgery. 
With capillary iontophoresis, multi-barrel capillaries became used in standard practice 
over the course of fifty years of experimental refinement, conventionally composed of two to 
nine barrels.144-149 In the most straightforward example, each barrel of the capillary assembly is 
filled with a solution of ionized drug and the solution is connected to an iontophoresis apparatus 
(typically a constant-current source) by a suitable electrical lead. The establishment of a potential 
difference between the drug solution and the medium surrounding the capillary tip causes the 
movement of ions from the tip, termed the ejection current.23 The direction of current flow is 
customarily defined as the flow of positive charges. Thus, an outward, or positive, current causes 
the ejection of cations, while an inward, or negative, current causes the ejection of anions. 
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Generally, a small retaining current is applied to prevent movement of the drug from the 
capillary tip into the extracellular environment due to diffusion and the hydrostatic pressure of 
the fluid within the capillary.23 This retaining current has the opposite direction of the ejection 
current. The discussion thus far, and the literature in general, has been limited to electrophoretic 
effects, despite the ejection capillary demonstrating a ζ-potential and the opportunity for 
electroosmotic flow. 
Iontophoresis is traditionally believed to be due to electrophoresis within the capillary 
and resulting diffusion in the tissue,136-139 despite the derivation of a relationship to explain the 
contribution of electroosmosis to iontophoretic drug delivery. According to Hill-Smith and 
Purves, Equation 3.1 gives the electroosmotic volume flow rate, Veo, within a capillary, where ε 
is the permittivity of the solution, i is the applied current, η is the solution viscosity, σ is the 
solution conductivity, and ζ is the ζ-potential of the capillary.150 
Veo  i  3.1
Thus, for a given solution, an increased electroosmotic flow rate can be achieved by increasing 
the applied current or by increasing the ζ-potential within the capillary. The relationship shown 
in Equation 3.1 was initially developed in 1978 to explain the diminished iontophoretic ejection 
of anionic molecules into cultured cardiac myocytes.150 Until recently, the literature was silent 
regarding electroosmosis within the capillary.151 
Experimental studies of the electrically induced release of ionized substances from 
capillaries, such as iontophoresis, must therefore include the contribution of electroosmosis. The 
transport number is used to mathematically describe the ejection, or flux, of ions from capillaries 
by an applied iontophoretic current. According to Equation 3.2, the molar flux, Q, is dependent 
on the applied current, i, the charge valency, Z, Faraday’s constant, F, and the transport number, 
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t.23, 150 
Q  it
FZ
 
3.2 
In current applications of capillary iontophoresis, such as the delivery of compounds into 
neurological tissue, theoretical descriptions do not take into account the contributions of 
electroosmosis and correspondingly do not utilize true transport numbers.23, 152, 153 Therefore, all 
experimentally observed “transport numbers” are only apparent values, and require an additional 
term to account for electroosmosis. The true transport number refers to the fraction of 
iontophoretic current carried by an ion, and can only be estimated by calculation after the 
contributions of electroosmosis are accounted for. Resultantly, a quantitative understanding of 
the drug efflux from the capillary tip has not been obtained.154-156 As there is currently an 
incomplete theoretical understanding regarding the transport number in iontophoretic ejections, 
researchers have used microelectrodes28, 157-162 and fluorescence microscopy163, 164 to measure the 
ejection profile of a solute outside of the capillary tip. 
Recently, Herr et al. showed that electrokinetic transport within the iontophoresis 
capillary was significant, and furthermore the authors were able to eject neutral solutes,151 
corroborating the theoretical description presented by Hill-Smith and Purves thirty years 
earlier.150 The magnitude of electroosmosis developed within a capillary is proportional to the 
capillary’s ζ-potential.20 The magnitude of the ζ-potential is governed by the surface charge 
density and the ionic strength of the bulk solvent.20, 23 Just as the incorporation of electroosmosis 
into transport models led to better predictions of solute delivery in transdermal iontophoresis,165, 
166 it must also be applied to capillary iontophoresis. 
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Recent work from our group has demonstrated that the ζ-potential of the matrix being 
ejected into plays a significant role in the ejection profile of a solute.164 In the three hydrogels 
prepared in Chapter 2 with varying ζ-potential, ejections of fluorescent dextran conjugates 
resulted in penetration distances that were dependent on the ζ-potential of the matrix.164 
Therefore, to more accurately define the ejection profile of a solute into biological tissue, the ζ-
potential of the tissue must be known. This previous work also developed a semi-empirical 
equation to describe the ejection profile of a solute outside of the capillary tip, which is 
fundamentally based upon electrokinetic transport in the hydrogel or OHSC, including the 
contributions from electrophoresis and electroosmosis, and diffusion.164 It has been postulated 
that electrokinetic transport within the tissue itself may account for the discrepancy between the 
predicted and experimental ejection profiles during capillary iontophoresis,167 however this 
theory was refuted as pulsed iontophoretic currents are traditionally very low (≤ 100 nA) and on 
too short of a timescale for electrokinetic transport to contribute significantly.137-139 While this 
may in fact be true for short, pulsed sequences, the contribution of electrokinetic transport in the 
tissue remains unknown for more sustained ejection times. 
This chapter evaluates the ejection profiles and the distances impacted resulting from 
ejections in the hydrogel models described in Chapter 2 and in OHSC. This work also exploited 
longer and more sustained ejection times than used in iontophoresis to approximate steady-state 
conditions to fit a theoretical description of the concentration profile from a capillary tip. 
Moreover, the effect of varying a solute’s size and electrophoretic mobility and the applied 
electrical current was evaluated over short-distance electrokinetic transport. Finally, analyzing 
the current density and tortuosity can account for variable penetration distances between 
equivalent hydrogels and OHSC. 
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3.2 THEORETICAL DESCRIPTION OF ELECTROKINETIC TRANSPORT IN 
TISSUE 
The theoretical derivation of the concentration profile of a solute emanating from a pulled 
capillary tip into a medium with a non-zero ζ-potential was recently derived,164 with a brief 
review provided herein. 
The Peclet number, Pe, is defined by Equation 3.3 as the dimensionless ratio of the time a 
molecule needs to diffuse a particular distance, a, and the time the molecule needs to move the 
same distance with a particular velocity, v, where D is the molecule’s diffusion coefficient. Thus, 
Pe can provide an indication of the relative degree of convection-enhanced delivery – as 
compared to diffusion alone – of a molecule from the capillary tip. 
Pe  va
D
 
3.3 
The concentration profile of a molecule being transported into tissue where μep and μeo 
are both zero is solely governed by diffusion. At steady-state, the diffusional concentration profile 
may be described by Equation 3.4, where the concentration, C, is a function of the concentration 
from hemispherical source with radius a, the maximal concentration within that hemispherical 
source, C0, and the distance from the hemispherical source, r.168 
C C0 ar  3.4 
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In contrast, when both convection and diffusion contribute to the transport from an iontophoresis 
capillary tip, the steady-state condition in the hemispherical coordinate system can be 
mathematically described by Equation 3.5. 
J Cv DC  
3.5 
where J and v are the flux and velocity of the molecule, respectively, and D is the diffusion 
coefficient of the molecule. The first term refers to the contribution of convection to overall flux, 
which includes veo and vep. The second term describes the contribution of diffusion to overall flux, 
which results from a concentration gradient, as described by Fick’s first law.30 It is assumed that 
the electric field emanating from the iontophoresis capillary tip into the medium of interest (i.e.: 
tissue) is equivalent to the field from a hemispherical electrode, as described by Equation 3.6, 
where the electric field, E, at a particular distance from the source, r, is related to the radius of the 
hemispherical source, a, and the maximum electric field where r is equal to a, E0. 
E(r)  a
2
r2
E0 
3.6 
The electric field determined by Equation 3.6 may be multiplied by the observed mobility, 
μobs, of a compound to arrive at the velocity term in Equation 3.5. The differential equation is 
solved to result in Equation 3.7, where Pe is the Peclet number. This expression describes the 
concentration of molecule expected at a dimensionless distance, ρ, during iontophoretic ejections. 
When electrokinetic effects become negligible (such as with no applied electric field), Pe is 
approximately zero. If the exponentials in Equation 3.7 are expanded as a Taylor series, with 
truncation of the quadratic and higher order terms, Equation 3.4 may be recovered. 
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C()  C0 1 e
Pe
1 ePe





 3.7 
3.3 EXPERIMENTAL 
3.3.1 Chemicals and Solutions 
The following materials were purchased from Sigma (St. Louis, MO) and used as 
received, unless otherwise noted. Solutions were prepared with Millipore Synthesis A10 system 
18 M purified water (Millipore, Billerica, MA). Glucose-free HEPES-buffered salt solution 
(GF-HBSS) contained in mM: 143.4 NaCl, 5 HEPES, 5.4 KCl, 1.2 MgSO4, 1.2 NaH2PO4, and 
2.0 CaCl2. GF-HBSS was filtered, stored frozen, warmed to room temperature, and 
ultrasonicated for ten minutes prior to use. HBSS contained the same component concentrations 
as GF-HBSS, with an additional 10 mM D-(+)-glucose, and underwent the same preparation and 
storage process. GBSS was made up of 27.5 mM D-(+)-glucose and 2.7 mM MgSO4 
supplemented to Gey’s Balanced Salt solution. GBSS was filtered, stored in the refrigerator, and 
warmed to 37 °C prior to use. The OHSC culture medium contained the following components 
from Gibco (Invitrogen, Eugene, OR): 50% Opti-MEM, 25% heat-inactivated Horse Serum, and 
25% Hanks’ Balanced Salt Solution, supplemented with 2% vitamin B-27 and 1% D-(+)-
glucose.169 The medium was filtered, stored in the refrigerator, and warmed to 37 °C prior to use. 
Texas Red dextran conjugate 70 kDa (TR70) and Texas Red dextran conjugate 3 kDa 
(TR3) were obtained from Invitrogen and diluted to 0.06 mM and 0.2 mM respectively with GF-
HBSS and filtered. The fluorophore solutions were frozen until use. Tris(2,2’-
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bipyridine)ruthenium (abbreviated Ru(bpy)32+) was obtained from Sigma and diluted to make a 
solutions of 1.3 mM Ru(bpy)32+ in 150 mM aqueous NaCl supplemented with 5 mM HEPES 
buffered at pH 7.4. A mixture of 0.19 mM TR70 and 0.29 mM FL70 in GF-HBSS was made for 
use in ζ-potential measurements, as described in Chapter 2. For the diffusion coefficient 
measurements, solutions were made in GF-HBSS to concentrations of: TR70 (0.03 mM), FL70 
(0.03 mM), TR3 (0.67 mM), and Ru(bpy)32+ (3.51 mM). For cell death analysis, a stock solution 
of 0.35 mM propidium iodide in GBSS was prepared and frozen until use. 
3.3.2 Determination of Free Diffusion Coefficients 
Diffusion coefficients were determined by Taylor dispersion measurements, as described 
in section 2.2.6. 
3.3.3 Determination of Electrophoretic Mobilities 
The electrophoretic mobilities of the fluorophores were determined in GF-HBSS by 
capillary zone electrophoresis (CZE) with a diode array UV absorbance detector using 50 m 
inner diameter (ID) fused silica capillaries and an Agilent CE system (Agilent Technologies, 
Palo Alto, Ca). Hydrodynamic injections (25 mbar, 4 second) were employed, and all 
experiments were performed at 25 °C. For TR70 (detection = 595 nm), TR3 (595 nm), FL70 (494 
nm), and Ru(bpy)32+ (452 nm), an unmodified fused silica capillary (Polymicro Technologies, 
Phoenix, AZ) was employed. The capillary was preconditioned with 1 M NaOH for 15 minutes, 
18 M-cm water for 15 minutes, GF-HBSS for 15 minutes, and was flushed with running GF-
HBSS for 2 minutes in between fluorophore injections. Rhodamine B (544 nm) was used as a 
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neutral flow marker. The capillary was 33.0 cm in total length, 8.5 cm to the detector, and the 
separation voltage was 6.0 kV (182 V/cm). Fluorophores were dissolved in GF-HBSS and had 
concentrations ranging from 0.3 to 1.7 mM. 
3.3.4 Synthesis of Hydrogels 
Poly(acrylamide-co-acrylic acid) hydrogels were prepared with the purpose of creating 
matrices with different ζ-potentials and tortuosities similar to those of brain tissue by a 
thermally-initiated radical polymerization reaction, as described in the procedure presented in 
section 2.2.3. 
3.3.5 Characterization of the ζ-Potential and Tortuosity 
The experimental apparatus was used without modification from our previously reported 
setup.22 A four-electrode potentiostat coupled with a differential amplifier and reference Luggin 
capillary electrodes was used to provide feedback control of the electric field in the gel. The ζ-
potential and tortuosity for each gel were determined with this setup,22 as described in greater 
detail in section 2.2.4. 
3.3.6 Water Content of Hydrogels 
The water content of each hydrogel was determined by dehydration and the mass of water 
lost, as described in section 2.2.7. 
 50 
3.3.7 Conductivity of Hydrogels 
Due to the high water content of the hydrogels, as determined in Chapter 2, the 
conductivity was assumed to be equivalent to the fluid (GF-HBSS). The conductivity of GF-
HBSS was measured using a CON 6/TDS 6 conductivity/TDS meter (Eutech Instruments Pte 
Ltd/Oakton Instruments, Vernon Hills, IL). 
3.3.8 Organotypic Hippocampal Slice Cultures (OHSC) 
The organotypic hippocampal slice culture (OHSC) method was developed by Stoppini et 
al.,92 and used with slight modification. This procedure was approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee. Bilateral dissections of the hippocampi 
were done on 9-day postnatal Sprague-Dawley albino rat pups. The hippocampi were chopped 
along their transverse axes using a McIlwain tissue chopper (Mickle Laboratory Engineering, 
Surrey, England) to yield 350 μm thick slices. The slices were positioned on 0.4 μm PTFE insert 
membranes (Millipore, Bedford, MA) and incubated over 1.2 mL of culture medium at 36.5 °C 
in 5 % CO2/95 % air for 6 to 8 days. The culture medium was exchanged every 2 to 3 days. Prior 
to use, the culture medium was substituted with 37 °C GBSS and incubated for thirty minutes. A 
second exchange with GBSS was conducted with for incubation for another 30 minutes. A final 
exchange to HBSS warmed to 37 °C was conducted and incubated for 30 minutes. 
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3.3.9 Electrokinetic Ejections into Hydrogels 
Borosilicate capillaries (1 mm by 0.58 mm, 4 inches long) with filaments (A-M Systems, 
Inc., Carlsborg, WA) were pulled to tips of approximately 2 μm inner radii using the Sutter P-
2000 capillary puller. Tip sizes and shape were measured using an Olympus BX41 optical 
microscope. Figure 3.1 shows a 0.25 inch thick PVC cell with a 1 cm by 1 cm space at its center. 
This cell has a 1 mm wide by 1 mm high by 2.2 cm long channel milled at its base. The cell was 
slightly larger than the standard cover slip glued to its base. The cell was secured on an Olympus 
IX-81 inverted fluorescence microscope stage, and experiments were imaged with a high-
resolution charged-coupled device camera (ORCA-ER). 
 
 
 
Figure 3.1. Experimental setup for electrokinetic ejections into hydrogels. A glass coverslip was affixed to the 
bottom of the PVC cell. A hydrogel square was placed in the center space of the cell. A pulled borosilicate capillary 
(pipette) was inserted into the hydrogel through the channel. On the other end of the channel, an Ag ground 
electrode was inserted into the hydrogel. 
 
Hydrogel pieces were cut and placed in the cell to completely cover the exposed glass 
cover slip below. The hydrogel thickness was greater than 5 mm in all instances. The pulled 
borosilicate capillary was carefully inserted through one side of the channel and into the 
hydrogel. On the other side of the channel, an Ag ground electrode (0.3 mm diameter) was 
inserted a few millimeters into the hydrogel. The distance between the capillary tip and the 
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ground electrode was always greater than 3.5 mm. A second Ag working electrode was inserted 
into the back end of the capillary to complete the electrical circuit. A Digital MidgardTM 
Precision Current Source iontophoretic pump (Stoelting Co., Wood Dale, IL) or Princeton 
Applied Research 173 potentiostat (PAR) (Princeton, NJ) were used as the constant current 
source. The current source was attached to the secured Ag electrodes through a circuit containing 
a relay switch, as reported previously.164 Image sequences were acquired using MetaMorph 
7.6.2.0 software (MDS Analytical Technologies, Sunnyvale, CA) using an UPlan Fl 4×, UPlan S 
Apo 10×, or a long working distance LUCPlan Fl N 40× Olympus objective lens. The 
MetaMorph software triggered the initiation and termination of the current during image 
acquisition. The PAR was used for TR70 with 0.1, 0.2, 0.4, 0.5, and 0.6 μA currents. 
Additionally, the PAR setup incorporated a 0.3 mm diameter platinum electrode as the working 
electrode (instead of Ag) to avoid capillary obstruction due to precipitation of AgCl. The 
MidgardTM pump or the PAR potentiostat monitored the electrical potential across the system as 
a constant current was applied. The currents ran from 270 to 840 seconds. 
The penetration distance was obtained from image sequences by utilizing a line scan 
from approximately the center of the capillary tip to the edge of the viewfield on the same plane 
as the injection capillary. The intensity data were recorded along the line scan prior to the 
initiation of current (to obtain the background intensity) and at 30 seconds intervals following 
initiation of the current. The background intensity was subtracted from the corresponding 
intensity along the line scan. Given that concentration is related to the fluorescence intensity 
measured, the concentration, C, was replaced in Equation 3.7 with intensity, I. The reported 
fluorescence intensity values were between 0 and 4,095. Values of I0, I1, and Pe were obtained 
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by nonlinear fitting of Equation 3.8 to the line scan data using Mathcad 14 (PTC, Needham, 
MA). I1 was included in this equation to correct for the background intensity. 
I()  I0 1 e
Pe
1 ePe





 I1 
3.8 
The dimensionless penetration distance, ρ, which was obtained from Equation 3.8 may be 
multiplied by the capillary tip radius to arrive at the penetration distance in SI units of distance, 
otherwise denoted as r. 
3.3.10 Electrokinetic Ejections into OHSC 
Experiments in the OHSC were conducted, as shown in Figure 3.2, with the Digital 
MidgardTM iontophoresis pump as the constant current source. An insert membrane with an 
OHSC was placed in a glass dish with HBSS. An Ag ground electrode was secured remotely and 
immersed in the HBSS bath. A pulled borosilicate capillary was filled with a fluorophore 
solution and positioned at a 20° angle versus the plane of the OHSC and insert membrane using a 
manipulator arm affixed to a Narishige NMN-21 micromanipulator (Tokyo, Japan). The 
capillary tip was introduced into the CA1 region of the OHSC. An Ag working electrode was 
inserted into the distal end of the capillary to make electrical contact. The electrode circuitry and 
imaging parameters were analogous to the hydrogel experiments.164 A 0.5 μA current was 
applied using the iontophoresis pump for up to 270 seconds. 
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Figure 3.2. Experimental setup for electrokinetic ejections into OHSC. An OHSC and its insert membrane are 
placed over HBSS in a glass dish. An Ag ground electrode is placed remotely in the bath. An Ag working electrode 
is placed distally in a borosilicate capillary that is inserted into the OHSC at a 20° angle. 
 
3.4 RESULTS AND DISCUSSION 
3.4.1 Fluorophore, Hydrogel, and Capillary Properties 
The free solution diffusion coefficients (D), as measured by the Taylor dispersion 
method, and the electrophoretic mobilities (μep) of the fluorophores, as measured by capillary 
zone electrophoresis, are provided in Table 3.1. As described in Chapter 2, TR70 demonstrated 
an approximately zero μep, while FL70 had a more negative μep. The small, divalent cation, 
Ru(bpy)32+, had a substantial and positive μep. Furthermore, the observed diffusion coefficients 
were inversely correlated with molecular weight and size. These two properties of the 
fluorophore helped determine the ejection profile and penetration distances resulting from 
electrokinetic ejections. 
To assess the relative degree of electrophoresis versus electroosmosis that was likely to 
be observed during electrokinetic transport of the solutes in the gels, a ratio of the ζ-potential of 
the hydrogels to the ζ-potential of the solute was compared to unity, as previously described.164 
 55 
All of these ratios were substantially larger than unity except for two conditions – TR70 and 
TR3 in the 0% acrylic acid hydrogel. Therefore, the transport of dextran conjugates in an applied 
electric field was dominated by electroosmosis within the more highly charged hydrogels with a 
ζ-potential similar to brain tissue. 
 
Table 3.1. Fluorophore properties (mean ± SEM). 
 Observed Free Diffusion Coefficient (D) 
(10-10 m2/s) 
Electrophoretic Mobility (μep) 
(10-9 m2/Vs) 
TR70 0.37 ± 0.02 
(N = 32) 
0.46 ± 0.03 
(N = 3) 
FL70 0.38 ± 0.01 
(N = 48) 
-8.80 ± 0.2 
(N = 3) 
TR3 1.05 ± 0.05 
(N = 48) 
2.56 ± 0.04 
(N = 3) 
Ru(bpy)32+ 3.70 ± 0.34 
(N = 48) 
25.86 ± 0.02 
(N = 3) 
 
The ζ-potentials, tortuosities, and fluid content of the hydrogels were extensively 
described in Chapter 2. Of note, the 25% w/w acrylate gel had a similar ζ-potential to the OHSC. 
Because the fluid fraction was so high in the hydrogels (roughly 96 to 98%), the electrical 
conductivity of the hydrogel was approximated as the fluid fraction of the hydrogel multiplied by 
the GF-HBSS buffer solution. The conductivity of GF-HBSS, was measured to be 1.62 S/m. At 
pH 7.40, GF-HBSS demonstrated an ionic strength of 0.15 M. 
The approximately -10 mV ζ-potential calculated for the borosilicate capillary was 
consistent with other forms of borosilicate glass.170-173 In addition, a ζ-potential of approximately 
-10 mV was also consistent with the experimental observation that the borosilicate capillary ζ-
potential must be more positive than -11 mV, as ζ-potentials less than -11 mV (and thus a greater 
magnitude) are capable of ejecting FL70 (μep = -8.8 × 10-9 m2/Vs)21 from the capillary tip. In 
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fact, no ejection of FL70 from the capillary into the -23.0 mV ζ-potential hydrogel was 
observed.164 
The rate of electroosmotic transport within the capillary tip may not equate to the same 
rate of electroosmotic transport outside of the tip. This may be due a difference between the ζ-
potential within the capillary and the ζ-potential of the matrix outside of the capillary. Two 
adjacent media with different ζ-potentials in an electric field create a pressure at the interface 
between the two media, in a phenomenon termed “ζ-potential mismatch.”20, 174 Thus, when the 
hydrogel ζ-potential magnitude is smaller than the capillary ζ-potential magnitude, such as with 
the lowest acrylic acid content hydrogels, the possibility exists for pressure development and 
hydrogel deformation near the tip. For example, if a solution containing a neutral molecule is 
ejected into a neutral gel, the Pe in the gel is theoretically zero. However, the negative ζ-potential 
within the capillary will result in expulsion of some of the solution into the hydrogel. This 
generates a positive pressure at the interface between the capillary tip and hydrogel, and thus 
provides the potential for pressure-driven transport, in addition to diffusional transport away 
from the tip. As a result, the Pe that is observed under these conditions may actually be greater 
than zero due to pressure-driven transport. The extent of the developed pressure relies on a 
myriad of factors, and therefore estimating its true effect is not trivial. No pressure deformation 
of the hydrogels or OHSC was observed during electrokinetic ejections, however. 
3.4.2 Time to Steady-State During Ejections 
Steady-state was defined in this work as a constant fluorescence intensity at ρ = 1 (just 
outside of the capillary tip) for more than two 30 second time intervals. Table 3.2 provides the 
times to reach steady-state for each experiment. The average times to steady-state for TR70 were 
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207 seconds and 233 seconds for 1.0 μA current ejections into the -0.25 and -9.5 mV ζ-potential 
hydrogels respectively. The same current for ejection of TR70 into the -23.0 mV ζ-potential 
hydrogel did not reach steady-state, however. The average times to steady-state for 1.0 μA 
current ejections of TR3 into the -0.25 and -9.5 mV ζ-potential hydrogels were 423 and 510 
seconds respectively. The same current for ejection of TR3 into the -22.1 mV ζ-potential 
hydrogel also did not reach steady-state. Taking this data as an example of a trend, increasing the 
ζ-potential, and by extension the degree of electroosmosis, of a medium subsequently increased 
its time to steady-state. Of note, the TR70 and TR3 experiments were truncated at 270 and 540 
seconds respectively (sometimes before reaching steady-state) due to the possibility of 
electrochemical reactions within the capillary and dehydration of the hydrogel during a 
prolonged experiment. 
 
Table 3.2. Experimental parameters for each data series. 
Solute 
Hydrogel 
ζ-Potential 
(mV) 
 
Current 
(μA) 
Average Time to 
Steady-State 
(seconds) 
Pe Pe SEM N 
TR70 -0.25 0.43 1.0 207 6 0.74 9 
TR70 -9.5 16 0.5 240 12 0.34 5 
TR70 -9.5 16 1.0 233 13 2.1 11 
TR70 -23.0 40 1.0 Non Steady-State 27 1.4 9 
TR70 -24.7 43 0.1§ 366 15 0.47 3 
TR70 -24.7 43 0.2§ 492 18 0.88 5 
TR70 -24.7 43 0.4§ 780 27 0.76 4 
TR70 -24.7 43 0.5§ 953 36 1.5 4 
TR70 -24.7 43 0.6§ 1030 39 4.6 3 
TR3 -0.25 0.077 1.0 423 16 0.36 11 
TR3 -15.2 4.7 0.5 498 37 1.3 13 
TR3 -15.2 4.7 1.0 510 51 1.3 8 
TR3 -22.1 6.8 1.0 Non Steady-State 52 3.2 10 
TR3 -24.7 7.6 0.5 Non Steady-State 69 4.9 6 
TR3 -24.7 7.6 1.0 Non Steady-State 73 2.5 6 
§Current applied through the PAR circuit. All other experiments were run using the Digital MidgardTM Precision 
current source. 
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Increasing the applied electrical current for TR70 ejections into the -24.7 mV ζ-potential 
hydrogel also increased the time to steady-state from 366 seconds at 0.1 μA to 1,030 seconds at 
0.6 μA (with 1.0 μA not reaching steady-state during the experimental time), as shown in Figure 
3.3. In contrast, ejections of TR3 into the same hydrogel were not at steady-state for any current 
tested. Our data indicated that smaller molecules require a longer time to achieve steady-state 
during constant-current ejections. Under constant-current conditions from a hemispherical 
microelectrode, comparable to the experimental setup described in this chapter, the time to 
steady-state depended on the diffusion coefficient of the molecule and the electrode size.175 With 
a constant capillary tip size, the time to steady-state also appeared to be correlated with 
molecular weight, as indicated by TR70 reaching steady-state much faster than TR3 for 
equivalent ejections. 
Steady-state is achieved when the flux of molecules through the capillary tip equals the 
flux of the same molecules away from the capillary tip into the matrix. These two processes may 
not always occur with the same rates, and thus one may be rate-limiting. These rates are a 
function of the ratio of the electroosmotic flow that exists between the capillary and the outside 
matrix, the diffusion coefficient of the molecule, and the tortuosity of the matrix. If the outside 
matrix was held at a constant -24.7 mV ζ-potential, as shown in Figure 3.3, the time to steady-
state was linearly dependent on the applied current for TR70 ejections (R2 = 0.994) from 0.1 to 
0.6 μA. Assuming this linear relationship holds at slightly higher currents, the time to steady-
state for 1.0 μA ejections of TR70 can be estimated as 1,610 seconds. This was not determined 
experimentally due to truncation of ejection times. In contrast, Table 3.2 indicates the time to 
steady-state for 1.0 μA ejections of TR70 as 207 seconds and 233 seconds in the -0.25 and -9.5 
mV ζ-potential hydrogels respectively. 
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Figure 3.3. Average time to steady-state for ejections of TR70 under variable currents in a hydrogel with -24.7 mV 
ζ-potential demonstrated a linear correlation with R2 = 0.994.
 
In the case of the -0.25 and -9.5 mV ζ-potential hydrogels, the capillary ζ-potential was of 
greater magnitude than that of the hydrogel. Thus, for a given current, the borosilicate capillary 
developed a greater degree of electroosmosis than the hydrogel, with a concomitant ejection. 
Because the flux of molecules through the capillary tip was larger than the transport of the 
molecules away from the tip and into the matrix, there was a faster accumulation of molecules 
just outside of the capillary tip at ρ = 1. This resulted in a shorter time to steady-state. 
Conversely, a similar ejection of TR70 into the -24.7 mV ζ-potential hydrogel demonstrated a 
much slower time to steady-state. In this instance, the magnitude of the hydrogel ζ-potential 
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greatly exceeded that of the borosilicate capillary. As a result, the transport of molecules away 
from the tip and into the matrix was larger than the flux of molecules through the capillary tip. 
This resulted in a slower accumulation of molecules just outside of the capillary tip at ρ = 1, with 
a resulting slower time to steady-state. 
 
 
Figure 3.4. Relationship of the average penetration distance (μm) where I(ρ)/I0 was equal to 0.25 with the average 
time to steady-state for ejections of TR70 in a hydrogel with -24.7 mV ζ-potential with 0.1, 0.2, 0.4, 0.5, and 0.6 μA 
demonstrated a linear correlation with R2 = 0.989.
 
Furthermore, the average penetration distance in micrometers, r, where I(ρ)/I0 was equal 
to 0.25 was also linearly correlated with the time to reach steady-state for TR70 ejections into a -
24.7 mV ζ-potential hydrogel with currents ranging from 0.1 to 0.6 μA (R2 = 0.989), as shown in 
 61 
Figure 3.4. This further supported the hypothesis that the rate of molecular transport away from 
the capillary tip determined the time to steady-state. The rate of electrokinetic transport away 
from the capillary tip into the matrix depends on the applied electrical current and the electric 
field at the capillary tip. Therefore the average penetration distance is greater for ejections with 
higher currents with a particular capillary tip size and at a given point in time. 
In hydrogels of varying ζ-potentials, the time to steady-state may also be correlated with 
the Peclet number. With transport solely due to diffusion, where Pe is zero, the time to steady-
state depends on the radius of the capillary tip. However, introduction of convective transport, 
such as though electrokinetic means, increases the Pe. Figure 3.5 shows the linear relationship 
between Pe and the time to steady-state for TR70 ejections into a -24.7 mV ζ-potential hydrogel 
with applied electrical currents ranging from 0.1 to 0.6 μA (R2 = 0.985). Since Pe was 
determined at ρ = 1 and was related to the flow rate of a molecule through the capillary tip, this 
data further substantiated the hypothesis that an increased time to steady-state may result from an 
increase in the flux of a molecule through the capillary tip. Similar to the discussion a moment 
ago, the electric field at the capillary tip determines the rate of electrokinetic transport away from 
the tip into the matrix. Increasing the applied electrical current has two effects: it increases the 
rate of fluid moving through the capillary tip resulting in a higher Pe, but it also increases the 
rate of electrokinetic transport away from the tip into the matrix, which ultimately results in a 
greater penetration distance at a given point in time. 
Finally, if a molecule with zero electrophoretic mobility is assumed, as is roughly the 
case for TR70, its observed velocity is the electroosmotic velocity of the solvent. The 
electroosmotic velocity through the capillary tip may be calculated from the Helmholtz-
Smoluchowski equation for each applied electrical current.20 The value of ζ used in this 
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calculation reflected the -10 mV ζ-potential of the borosilicate capillary.170-173 The volumetric 
flow rate through the capillary tip was linearly related to the average time to steady-state for 
TR70 ejections, as shown in Figure 3.6 (R2 = 0.994), indicating that increased an increased flow 
rate resulted in an increased time to steady-state in a hydrogel with a ζ-potential similar to 
OHSC. 
 
 
Figure 3.5. Relationship of Peclet number (Pe) with the average time to steady-state for ejections of TR70 in a 
hydrogel with -24.7 mV ζ-potential with 0.1, 0.2, 0.4, 0.5, and 0.6 μA demonstrated a linear correlation with R2 = 
0.985. 
 
Thus, this discussion has described the factors correlated with the time required to 
achieve steady-state. These factors include varying the applied current, the ζ-potential of the 
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medium outside the capillary tip, the penetration distance a molecule achieves, Pe, and the flow 
rate from the capillary tip. Furthermore, the time required to reach steady-state could be 
especially long with certain experimental parameters, such as with larger capillary tip sizes due 
to an increased flow rate. 
 
 
Figure 3.6. Relationship of the average time to steady-state (sec) with the volumetric flow rate through the capillary 
tip for ejections of TR70 in a hydrogel with -24.7 mV ζ-potential with 0.1, 0.2, 0.4, 0.5, and 0.6 μA demonstrated a 
linear correlation with R2 = 0.994. 
 
3.4.3 Evaluation of the Penetration Distance During Ejections 
Fitting the fluorescence intensity profiles to Equation 3.8 yielded values for Pe, in 
addition to characteristic penetration distances where I(ρ)/I0 was equal to 1, 0.75, 0.50, and 0.25. 
The fits for each experiment produced R2 greater than 0.98, despite some hydrogels (-23.0 and -
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24.7 mV ζ-potential) only approaching steady-state with 1.0 μA in the experimental time frame. 
The dimensionless penetration distance, ρ, which was obtained from Equation 3.8, may be 
multiplied by the capillary tip radius to arrive at the penetration distance in SI units of distance, 
otherwise denoted as r. The results of these experiments are shown in Table 3.3.164 
The nearly neutral dextran conjugate, TR70, represents a marker for electroosmosis 
occurring within each hydrogel. Of note, TR3 was carried much deeper into the hydrogels, 
presumably due to its slightly positive electrophoretic mobility, smaller molecular size, and 
lower tortuosity in the hydrogel matrix. In the hydrogels with biologically-similar ζ-potentials of 
-23.0 and -24.7 mV, r where I(ρ)/I0 was equal to 0.25 were approximately 90 and 330 μm for 1.0 
μA ejections of TR70 and TR3 respectively. In contrast, similar 1.0 μA ejections of TR70 and 
TR3 in the hydrogel with the lowest ζ-potential (-0.25 mV) yielded r where I(ρ)/I0 was equal to 
0.25 of only roughly 25 and 115 μm respectively. Thus, a matrix with a higher magnitude ζ-
potential outside of the capillary tip developed a greater degree of electrokinetic transport with a 
resultantly greater penetration distance. 
 
Table 3.3. Penetration distances for TR70 and TR3 as a function of hydrogel ζ-potential (data mean ± SEM). 
Solute 
Hydrogel 
ζ-Potential 
(mV) 
Current 
(μA) 
ρ 
I(ρ)/I0 = 0.75  
ρ 
I(ρ)/I0 = 0.50  
ρ 
I(ρ)/I0 = 0.25  Pe N 
TR70 -0.25 ± 0.04 1.0 2.80 ± 0.20 6.42 ± 0.57 16.37 ± 1.52 6.0 ± 0.7 9 
TR70 -9.5 ± 0.2 1.0 8.07 ± 0.68 15.28 ± 1.62 28.46 ± 2.60 13.4 ± 2.1 11 
TR70 -23.0 ± 0.3 1.0 16.70 ± 0.88 27.94 ± 1.05 45.47 ± 1.46 27.3 ± 1.4 9 
TR3 -0.25 ± 0.04 1.0 8.86 ± 0.41 22.88 ± 0.54 57.93 ± 1.93 16.2 ± 0.4 11 
TR3 -15.2 ± 0.8 1.0 18.21 ± 1.37 47.68 ± 2.92 113.60 ± 3.57 44.3 ± 2.6 13 
TR3 -22.1 ± 0.6 1.0 22.57 ± 1.20 57.62 ± 3.12 132.58 ± 6.56 51.9 ± 3.2 10 
 
Furthermore, the penetration distances for the 0% acrylic acid hydrogel (ζ = -0.25 mV) 
should be similar to that for diffusion alone for molecules with an electrophoretic mobility equal 
to zero. However, the penetration distances of both TR3 and TR70 in the 0% acrylic acid 
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hydrogels were considerably larger than the distance calculated for diffusion alone.164 It is likely 
that there was some contribution from pressure-induced transport in these instances due to ζ-
potential mismatch. Moreover, there was a significant transport contribution from electrophoresis 
in the case of TR3, in addition to the possibility for pressure involvement. 
With a particular capillary tip size, the most direct method to control Pe and the ejection 
profile was to alter the applied electrical current or alter the ζ-potential of the medium being 
ejected into (which is not readily achievable for biological tissue). The fluorescence intensity at ρ 
= 1, corresponding to the maximal concentration of a molecule ejected just outside of the tip, and 
Pe were both linear functions of the applied current from 0.1 to 0.6 μA.164 Increasing the current 
resulted in an approximately linear increase in the fluorescence intensity at ρ = 1, and 
concomitantly the concentration of ejected solute just outside the tip (R2 = 0.985).164 Moreover, 
there was a linear relationship between Pe and the applied current over the range of experimental 
currents (R2 = 0.988).164 This quantitative linear correlation has been previously described by 
Guy, though no other literature illustrated this relationship,23, 151, 163, 164 likely due to capillary 
iontophoresis ejections not occurring at steady-state and instead at very short timescales. 
The maximum concentration for molecules with a zero or positive electrophoretic 
mobility that is achievable just outside of the capillary tip is related to the concentration of the 
molecule within the ejection capillary, if a pressure does not develop as a result of ζ-potential 
mismatch and no difference exists between a molecule’s velocity within the capillary and the 
outside medium. As these molecules are ejected, they are electrokinetically transported from the 
capillary tip or simply diffuse away. 
In the case of ζ-potential mismatch, the development of a significant pressure just outside 
the capillary tip can produce further buildup of the molecule, which may even slightly exceed the 
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concentration inside the capillary. The pressure resulting from ζ-potential mismatch is also a 
function of the applied electrical current.20 While it may still be possible to eject a molecule with 
a negative electrophoretic mobility from the capillary tip, its negative electrophoretic mobility 
may also slow its electrokinetic transport away from the capillary tip. In contrast, the solvent 
molecules may still undergo electroosmotic transport away from the tip. Thus, an even greater 
concentration of the molecule accumulates just outside of the capillary tip. 
This can be semi-quantitatively compared with a ratio of the electrophoretic mobility to 
the electroosmotic mobility. The electroosmotic mobility of the ejected solvent is provided by 
the Helmholtz-Smoluchowski equation, and is equal to -εζ/η.20 For a borosilicate capillary with a 
ζ-potential of approximately -10 mV,170-173 the electroosmotic mobility of the solvent was 7.8 × 
10-9 m2/Vs. Therefore, when the electrophoretic mobility of a solute is more negative than -7.8 × 
10-9 m2/Vs, as with FL70, the molecule will not be ejected from the capillary. For the sake of 
further illustration, consider a molecule with an electrophoretic mobility of -5 × 10-9 m2/Vs. It 
will still be ejected from the borosilicate capillary; however, its negative electrophoretic mobility 
slows its electrokinetic transport away from the capillary tip, while the velocity of the solvent 
remains proportional to the electroosmotic mobility within the outside medium and the electric 
field. 
In addition, a flux balance of a molecule through the capillary tip exists at steady-state. If 
the velocity in the hydrogel is less than the velocity in the capillary, then the concentration of a 
molecule within the gel must be higher than the concentration inside the capillary. For 
borosilicate capillaries ejecting into a hydrogel with no ζ-potential, the velocity outside of the 
capillary is a product of diffusion alone and is expected to be slower than the velocity inside the 
capillary. As such, the concentration of a molecule outside of the capillary is expected to exceed 
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the concentration within the capillary. However, in a hydrogel with a ζ-potential similar to brain 
tissue (i.e.: a ζ-potential of -22 to 25 mV), the electrokinetic velocity is expected to be greater 
than the velocity inside a borosilicate capillary (ζ-potential of approximately -10 mV).170-173 For 
flux balance to exist in this situation, the concentration outside the capillary tip cannot exceed the 
concentration inside the capillary. 
Ultimately, as currents are increased beyond the 0.6 μA that have been previously 
examined,164 it is theoretically possible for the linear relationship between the applied current 
and the maximum fluorescence intensity outside the capillary tip to degenerate due to ζ-potential 
mismatch between the capillary and outside medium and with molecules of different 
electrophoretic mobilities. Flux balance also dictates the maximum concentration, and therefore 
the fluorescence, achievable outside of a capillary tip. 
Furthermore, the dimensionless penetration distances where I(ρ)/I0 was equal to 0.75, 
0.50, and 0.25 were also correlated with the applied electrical current. As shown in Figure 3.7, 
increasing the applied current from 0.5 to 5.0 μA for TR70 ejections into a -9.5 mV ζ-potential 
hydrogel resulted in a linear increase in the dimensionless penetration distances with R2 greater 
than 0.99 in all instances. This same trend held for TR3 ejections also, with analogous linear 
correlations having R2 greater than 0.99. Therefore, it can be concluded that increasing the 
applied current not only increased Pe and the fluorescence intensity just outside of the capillary 
tip, but that it also increased the penetration distances achieved by a molecule. This is consistent 
with the hypothesis that the rate of electrokinetic transport outside of the capillary tip increases 
with higher applied currents, and may therefore transport a molecule over a further distance. 
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Figure 3.7. Impact of the current (i) on TR70 ejection penetration distances (ρ) in a -9.5 mV ζ-potential hydrogel, 
where I(ρ)/I0 equal to 0.75 (diamonds), 0.50 (squares), and 0.25 (triangles). Values are taken at 270 seconds.
 
If a molecule with zero electrophoretic mobility is assumed, as is roughly the case for 
TR70, its observed velocity is the electroosmotic velocity of the solvent. The electroosmotic 
velocity through the capillary tip may be calculated from the Helmholtz-Smoluchowski equation 
for each applied electrical current.20 The value of ζ used in this calculation reflected the -10 mV 
ζ-potential of the borosilicate capillary.170-173 The volumetric flow rate through the capillary tip is 
linearly related to the penetration distance in micrometers for TR70 ejections, as shown in 
Figure 3.6 (R2 = 0.978). 
For a given porous matrix with a ζ-potential, the volumetric flow rate through the 
capillary tip was correlated with the average penetration distance in micrometers where I(ρ)/I0 
was equal to 0.25. For a given solution composition, the volumetric flow rate depends on the ζ-
potential of the capillary, the electric field (and the applied electrical current), and the cross 
sectional area of the capillary tip. The y-intercept for the equation presented in Figure 3.6 
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indicates that even with no flow through the capillary tip, the average penetration distance in 
micrometers where I(ρ)/I0 is equal to 0.25 still occurs at 62.6 μm. This can be rationalized in the 
following way: the penetration distance is also a function of the degree of electroosmotic flow 
developed in the matrix outside of the capillary tip and diffusion. With miniscule flow rates due 
to an extremely low applied electrical current, electroosmotic flow and diffusion still occur to 
some extent outside of the capillary tip resulting in a greater than expected penetration distance. 
 
 
Figure 3.8. Relationship of the average penetration distance (μm) where I(ρ)/I0 was equal to 0.25 with the 
volumetric flow rate through the capillary tip for ejections of TR70 in a hydrogel with -24.7 mV ζ-potential with 
0.1, 0.2, 0.4, 0.5, and 0.6 μA demonstrated a linear correlation with R2 = 0.978.
 
Finally, it should be noted that with the extremely small capillary tips utilized in these 
experiments, with radii of ranging from roughly 1.5 to 2 μm, that fluorescent dextran conjugates 
may be transported over a relatively large distance. The penetration distance corresponding to 
I(ρ)/I0 equal to 0.25 for the TR70 dextran conjugate in the highest ζ-potential magnitude 
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hydrogel (the hydrogel with ζ-potential closest to OHSC) was approximately 90 μm. The 
analogous penetration distance for TR3 was approximately 330 μm. The typical size of a 
pyramidal neuron soma in OHSC is roughly 20 μm,90 thus the penetration distances achieved 
with this method describe more extended ejections that may impact a local region and several 
neurons. Furthermore, the penetration distance appeared to be correlated with molecular weight 
and the applied electrical current. In the case of TR3, it also has an appreciably positive 
electrophoretic mobility and experienced a lower tortuosity. 
3.4.4 Ejections Into OHSC 
The penetration distances for TR70 ejections from a capillary tip positioned into CA1 of 
an OHSC with 0.5 μA were also determined.164 Bright field imaging taken during the ejection 
demonstrated that the application of 0.5 μA of current created no visible distortion of the tissue. 
Moreover, 0.5 μA ejections into the CA1 of OHSC for up to 300 seconds demonstrated no 
increased cell death at the ejection site when compared to controls by propidium iodide 
staining.164 
Steady-state iontophoretic ejections of TR70 into the OHSC using 0.5 μA (r = 108.6 μm) 
traveled only two-thirds the distance, where I(ρ)/I0 was equal to 0.25, than similar ejections of 
TR70 into a -23.0 mV ζ-potential hydrogel using a 0.5 μA current (r = 164.5 μm).164 Current 
was applied for the same amount of time in both cases. Why may a molecule travel a different 
distance in the OHSC than in a hydrogel with similar ζ-potential applied current? Perhaps the 
answer lies in understanding the tortuosity, current density, and electric field profile in the OHSC 
versus the hydrogel. 
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First, the current density and electric field profile are analyzed. The extracellular fluid 
content of the OHSC was initially determined to be roughly 20%,28, 164 whereas the fluid content 
of the hydrogels ranged from approximately 96 to 98%. Thus, the electrical current experienced 
a more restricted path than in the OHSC than in the hydrogels, due to less fluid space, as it 
traveled through the extracellular space. As a result, the resistance to current flow was higher in 
the OHSC than in the hydrogels. Thus, Ohm’s law dictates that the current is lower in the OHSC 
than in the hydrogels at a particular distance away from a specific electric field emanating from 
the capillary tip.176 The magnitude of electrokinetic transport in the OHSC was therefore less 
than in the hydrogels for a given applied current and distance away from the capillary tip, though 
its overall ejection profile shape was very similar to those in hydrogels (fitting the experimental 
OHSC data to Equation 3.8 resulted in R2 greater than 0.98). 
The electric field and current density at the point where I(ρ)/I0 was equal to 0.25 can be 
determined for a -24.7 ± 1.7 mV ζ-potential hydrogel and OHSC (ζ-potential of -22.8 ± 0.8 
mV)22 for an 0.5 μA applied current. The OHSC has an extracellular space free volume, α, of 
20%,28 and the 25% acrylic acid hydrogel has an α of approximately 98%. As the electrical 
current passes primarily through the fluid spaces, the electrical conductivity of the extracellular 
fluid (σf) – taken as GF-HBSS – can be multiplied by α for a given medium to arrive at an 
estimation for the conductivity for the medium (σm); thus, the σm for OHSC was estimated to be 
0.32 S/m and σm for the hydrogel was estimated to be 1.59 S/m. The electric field at the tip (E0) 
was calculated as the applied electrical current divided by σf. The electric field where I(ρ)/I0 was 
equal to 0.25 multiplied by the capillary tip radius (thus the penetration distance, r, had SI units 
of distance), termed here as Er, was determined by Equation 3.6. Finally, the current density at 
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the same distance, Ji(r), was calculated by multiplying Er by σm, with the results shown in Table 
3.4. 
 
Table 3.4. Determination of the current density, Ji(r), at the point where I(ρ)/I0 was equal to 0.25 away from the 
capillary tip (r) for TR70 ejections in a hydrogel and OHSC. 
 
 Current (μA) 
E0 
(V/m) 
Er 
(V/m) 
σ 
(S/m) 
r 
(10-6 m) 
Ji(r) 
(A/m2) 
25% Hydrogel 
(α = 98%) 0.5 26,100 3.6 1.588
 164.5 5.8 
OHSC 
(α = 20%) 0.5 23,840 8.3 0.324
 108.6 2.7 
OHSC 
(α = 40%) 0.5 23,840 8.3 0.648
 108.6 5.4 
Note: Free volume is denoted as α. 
 
Table 3.4 shows that Ji(r) for the OHSC was significantly different when α was assumed 
to be 20% or 40%, with the result from the 40% estimation providing a Ji(r) that was similar to 
the hydrogel. This result can be analyzed in two ways: that the rate of electrokinetic transport 
depended on changes in free volume, which has previously been refuted,174, 177 or that the free 
volume of the OHSC was not actually 20% (and in fact was closer to 40%). Furthermore, the 
free volume of the hippocampus was measured in acute hippocampal slices immersed in an 
artificial cerebrospinal fluid solution obtained from postnatal (p4 to p7) rats, and had an α of 0.41 
± 0.01 (N = 10).178 This result was roughly twice as large as the free volumes determined in the 
adult rat hippocampus.42, 43, 45 
Moreover Ji(r) in the OHSC, assuming α equal to 40%, was similar to that of the 
hydrogel though the ultimate penetration distance was less (r = 108.6 μm, Ji(r) = 5.4 A/m2 and r 
= 164.5 μm, Ji(r) = 5.8 A/m2 respectively). Thus, r occurred when the current density was only 
0.01% of its maximum at the capillary tip in both media for TR70 ejections. At any particular 
distance from the capillary tip, the current density was higher in the hydrogel than in the OHSC. 
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At a specified distance of 108.6 μm from the capillary tip, the current density was calculated as 
13.2 A/m2 in the hydrogel and only 5.4 A/m2 in the OHSC. Because the current density is lower 
in the OHSC compared to the hydrogel, electrokinetic transport occurs to a smaller degree at any 
given distance from the capillary tip. 
Finally, electrokinetic transport of a molecule through the extracellular space of OHSC, 
hydrogels, or in vivo brain tissue must also account for differences in tortuosity. The tortuosity 
determined for TR70 in the hydrogel and OHSC were 1.71 ± 0.18 and 2.24 ± 0.10 respectively.22 
In particular, the frictional drag force that exists in the OHSC and hydrogels may be strikingly 
different (see discussion in Chapter 1). The OHSC has a free volume that is less than half of that 
of a hydrogel, and it can be expected that a large, flexible 70 kDa molecule would experience a 
greater frictional drag force resulting in a decreased penetration distance. 
3.5 CONCLUSIONS 
Under the set of conditions for the experiments in this chapter, the transport of a molecule into a 
porous, aqueous medium strongly depended on the ζ-potential of the medium. Furthermore, a 
molecule’s penetration distance was affected by properties of the solute (such as the 
electrophoretic mobility and molecular weight), the applied current, the flow rate through the 
capillary tip, and properties outside of the capillary tip, such as the medium’s ζ-potential, its 
conductivity, and its tortuosity. Consequently, this methodology may be applied to living 
systems for molecular transport over distances of up to several hundred micrometers. The work 
developed in this chapter sets the foundation for the development of subsequent chapters, 
 74 
whereby the penetration distances will be expanded to clinically relevant distances and this 
methodology will be elucidated in vivo. 
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4.0  LOCALIZED DELIVERY OF MOLECULES FOR THE TREATMENT OF 
MALIGNANT BRAIN GLIOMAS 
4.1 MALIGNANT GLIOMAS 
Malignant gliomas account for approximately 70% of new malignant primary brain tumor 
diagnoses each year in the United States.179 Moreover, gliomas are associated with 
disproportionately high morbidity and mortality, with only a 12 to 15 month median survival for 
patients with glioblastomas and 2 to 5 years for patients with anaplastic gliomas, irrespective of 
treatment.179 Gliomas represent a category of malignant primary brain tumors that originate from 
the supporting cells – oligodendrocytes and astrocytes – of the central nervous system. The 
tumors are histologically disparate and are classified into four prognostic grades: grade I 
(pilocytic astrocytoma), grade II (diffuse astrocytoma), grade III (anaplastic astrocytoma), and 
grade IV (glioblastoma). Grade III and IV tumors are considered as malignant gliomas.179 
Malignant transformation in gliomas may be a ramification resulting from the accrual of 
genetic aberrations and de-regulation of cellular signaling pathways (particularly involved in cell 
division and growth factor signaling).179-181 Several “molecular markers” for gliomas exist and 
are applied diagnostically. Primary glioblastomas generally manifest in patients older than 50 
years of age, and are categorized by mutations and amplification of the epidermal growth factor 
receptor (EGFR), loss of heterozygosity of chromosome 10q, excision of the phosphatase and 
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tensin homologue on chromosome 10 (PTEN), and p16 deletion.179, 181, 182 In contrast, secondary 
glioblastomas occur in younger patients as low-grade or anaplastic astrocytomas, and transform 
over a period of several years into higher-grade tumors or glioblastomas. They are characterized 
by mutations in the p53 tumor suppressor gene, increased expression of the platelet-derived 
growth factor receptor (PDGFR), loss of heterozygosity of chromosome 10q, and aberrations in 
the p16 and retinoblastoma (Rb) pathways.179, 181-183 Moreover, these two types may be 
distinguished by differences in transcriptional patterns and irregular DNA copy numbers.180 
4.2 CURRENT THERAPEUTIC STRATEGIES FOR GLIOMAS 
The current standard therapy for newly diagnosed malignant gliomas involves surgical resection 
when feasible, radiotherapy, and chemotherapy.179, 184 This multimodal treatment strategy is a 
result of the infiltrative nature of gliomas. As a result, complete surgical resection is not possible, 
and adjuvant therapy is required. The addition of radiotherapy – 60 Gy of external beam 
irradiation delivered 5 days per week in fractions of 1.8 to 2.0 Gy as a convention – to surgery 
increases survival amongst patients from a range of 3 to 4 months to a range of 7 to 12 
months.179, 185, 186 However, even with this standardized therapy, 90% of the tumors recur within 
2 centimeters of the original site.186 A 2005 phase III trial with comparing the aforementioned 
radiotherapy alone to radiotherapy plus temozolomide, an oral DNA alkylating chemotherapy 
agent, demonstrated an acceptable side-effect profile and, as compared with radiotherapy alone, 
increased median survival from 12.1 months to 14.6 months.184 Moreover, the survival rate at 
two years amongst the patients who received radiation and temozolomide was 26.5%, and was 
significantly greater than the 10.4% survival rate amongst patients receiving radiation alone.184 
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This landmark clinical trial established a new standard of care known as the Stupp regimen,184 
utilizing radiation with concomitant and adjuvant temozolomide for newly diagnosed 
glioblastomas. However, tumor recurrence still remains a significant issue despite this therapy, 
with more than 72% of tumor recurrence within the radiotherapy field and tumor resection 
margins.187 Moreover, the therapeutic window for temozolomide dosage is narrowed because of 
its systemic administration and resultant myelotoxicity.188 
Prior to the establishment of this new standard of care, investigators took note of this 
predilection for local recurrence of glioblastoma. Two primary strategies for the localized 
delivery of chemotherapy were developed – implantable polymeric wafers and pressure-driven 
infusion. Despite the advent of the Stupp regimen, significant ongoing research seeks to 
understand and apply these two strategies to clinical patient care. These two methods circumvent 
systemic toxicities, and instead administer chemotherapy to a localized area within the brain 
itself. 
4.3 DIFFUSION-BASED BIODEGRADABLE WAFERS 
Biodegradable polymer wafers (Gliadel® wafers) containing carmustine were approved by the 
FDA in 1999 and implanted into the tumor bed following resection, with a gradual diffusion-
based release of carmustine to affect residual localized tumor cells.189 In a randomized, placebo-
controlled phase III trial in newly diagnosed malignant gliomas, the median survival in treated 
patients increased from 11.6 months to 13.9 months with this survival advantage maintained at 2 
and 3 years.190, 191 Diffusion is the motivating force behind chemotherapy penetration into the 
brain tissue with this technique. Pharmacokinetic and distribution studies in non-human primates 
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have determined that Gliadel® releases carmustine over a 5 day period when in complete contact 
with interstitial fluid, with biodegradation of the wafers occurring over a period of 6 to 8 
weeks.192 Animal and computational studies have demonstrated millimolar concentration dose-
delivery within millimeters of the wafer, with limited spread of carmustine at further 
distances.192 However, a study in non-human primates demonstrated significant convective flow 
due to postsurgical edema that augmented the diffusion of carmustine with the drug being 
detected over a centimeter away for up to a week following wafer implantation.193 
Because wafer implantation requires an invasive craniotomy and tumor resection, there 
are limited opportunities for placement. A large clinical trial reported a greater occurrence of 
cerebrospinal fluid leak and intracranial hypertension in patients who received Gliadel® versus 
placebo (5% versus 0.8% and 9.2% versus 1.7% respectively), which may result in reoperation 
or ventricular drain placement.190 Moreover, malignant gliomas typically develop deep within 
the subcortical white matter and periventricular zones, and may not be amenable to resection 
(and thus Gliadel® implantation).179 Finally, Gliadel® (carmustine) may preclude patients from 
entering some ongoing clinical trials with newly developed chemotherapy agents. 
4.4 CONVECTION-ENHANCED DELIVERY UTILIZING PRESSURE 
Pressure-driven infusion of molecules was first described in 1994 to introduce locally high 
concentrations of macromolecules and small molecules into the brains of cats.194 In this initial 
study, the volume of distribution to volume of infusion (Vd / Vi) ratios were 6:1 and 13:1 for a 
radiolabeled transferrin macromolecule and radiolabeled sucrose molecule respectively.194 The 
Vd / Vi ratio describes the difference between the volume of infusate introduced into the brain 
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relative to its ultimate distribution at a particular timepoint. The infusates were introduced over 1 
to 4 hours with flow rates that were gradually increased from 0.5 to 4 μL/min. Quick calculation 
yields that these parameters result in a range of infusion volumes of approximately 30 μL (0.5 
μL/min for 60 min) to 960 μL (4 μL/min for 240 min). Immediately after perfusion, transferrin 
dispersed approximately 1.5 cm and sucrose dispersed approximately 2.0 cm in the anterior-
posterior plane, though this infusion was predominately within the white matter (less dense, 
more free volume) with partition into the gray matter (more dense, less free volume) occurring 
much later.194 The authors termed the pressure-driven infusion of molecules “convection-
enhanced delivery,” as the distribution volume observed was greater than could occur by 
diffusion alone in the same time frame. 
This pressure-driven infusion was extensively evaluated over the subsequent ~17 years 
until present day. In a rat model, the effects of varying the rate of infusion, cannula size, 
concentration of the infusate, and pre-infusion sealing time to allow tissue accommodation of the 
infusion cannula were evaluated.195 Only the rate of infusion and cannula size significantly 
altered the convective distribution of the infused molecule. Of note, the authors described 
significant backflow and infusate leak along the implanted cannula tract, which resolved at 
infusion rates less than 1 μL/min. Percentage of leak and backflow observed at 1 and 5 μL/min 
were 22.7 ± 11.7% and 30.3 ± 7.8% respectively (mean ± standard deviation).195 Clearly, 
backflow represents a significant obstacle with pressure-driven delivery despite refinement of the 
cannula tip,196-200 which limits the rate of infusion and subsequent volume of drug distribution. It 
should be noted that at very low infusion volumes ranging from 80 to 120 μL, no neurological 
deficit or tissue deformation was observed in non-human primates.201 However, subcortical 
infusion in a canine glioma model demonstrated significant ventricular compression due to mass 
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effect.202 The infusion volume that caused complete ventricular occlusion was determined to be 
407 ± 59 μL in dogs and 672 ± 52 μL in non-human primates.202 The authors of this study 
commented that ventricular compression in humans would be a serious complication requiring 
immediate neurosurgical intervention.  
Over the previous decade, more than 17 clinical trials have examined the efficacy and 
safety profile of “convection-enhanced delivery” in human patients. In one of the first clinical 
trials to release safety data that included 22 human patients with glioblastoma, 59% of the 
adverse effects related to catheter placement and infusion were neurological or psychiatric with 
9% due to infection; the most common adverse effects included headache, gait disturbance, and 
fever.203 In other human clinical trials, pressure-driven infusion into brain tumors resulted in 
seizure activity and hemiparesis from peritumoral edema and mass effect.204, 205 Several animal 
models and small human clinical trials demonstrated that the infusion volumes and infusion rates 
were limited by deep tissue deformation, separation of white matter tracts, and tearing, leakage 
of the infusate into the cerebrospinal fluid spaces or prior resection beds/catheter tracts as they 
represent areas of least pressure resistance, and resultantly unpredictable intraparenchymal drug 
delivery.195, 202, 203, 205-210 Additional limitations became increasingly evident in a large human 
clinical trial, the PRECISE trial.211 
In the PRECISE trial (296 patients with glioblastoma), variability of placement of the 
infusion catheter was significant despite rigorous training and protocol development with only 
49.8% of catheters placed appropriately.211, 212 Catheter placement had significant effect on 
progression-free survival with recurrent glioblastoma.211, 212 Moreover, coverage of relevant 
target areas was low, with only 20.1% of the 2 cm penumbra surrounding the resection cavity 
covered by the infusate on average.211, 212 As expected, delivery to target areas correlated with 
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catheter placement and progression-free survival.211, 212 The results for this clinical trial were 
somewhat discouraging, as a major limitation involved placement of the infusion catheter and the 
subsequent directionality of flow from the catheter tip. 
To sum up pressure-driven infusion (“convection-enhanced delivery”), an infused drug is 
able to penetrate a much further distance than by diffusion alone (such as with Gliadel® wafers). 
However, infusion under constant pressure may produce transient deformation of brain tissue, 
potential tissue tearing and leakage of the infusate into prior resection beds/catheter tracts or the 
cerebrospinal fluid spaces or the brain, ineffective and unpredictable infusion profiles due to 
catheter placement and backflow up along the catheter itself, and an inability to reliably direct 
the infusion to the target site. Just as Gliadel® wafers are more suited for cortical or surface 
lesions, pressure-driven infusion is more suitable for deeper lesions, as attempts to infuse 
superficial brain areas result in spreading of the infusate across the cortical surface. 
The following chapter describes the development, preliminary optimization, and in vivo 
proof-of-principle for an electroosmotic convection-enhanced delivery system that may address 
many of the limitations observed with pressure-driven infusion. 
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5.0  LARGE-DISTANCE ELECTROKINETIC INFUSION OF MACROMOLECULES 
AND SMALL MOLECULES IN A GEL MODEL, ORGANOTYPIC HIPPOCAMPAL 
SLICE CULTURES, AND IN VIVO 
5.1 INTRODUCTION 
Building upon the experiments conducted previously164 and in Chapter 3, whereby 
macromolecules and small molecules were transported over distances up to a few hundred 
micrometers from the capillary tip, this chapter seeks to address the clinical limitations 
encountered by pressure-driven convection-enhanced delivery for the treatment of malignant 
gliomas.195, 202, 203, 205-212 This methodology examines drug infusion and penetration over a 
significantly greater distance than is achievable by diffusion alone (such as with Gliadel® 
wafers).189-192 Moreover, infusion under constant pressure may generate a transient deformation 
of the brain tissue with temporary (or possibly permanent) neurological deficit.204, 205 
Furthermore, the potential exists for tissue tearing and leakage of the infusate into prior resection 
beds or catheter tracts or even the cerebrospinal fluid spaces or the brain.211, 212 Clinical trials for 
pressure-driven delivery were limited by ineffective and unpredictable infusion profiles as a 
result of improper catheter placement and backflow along the catheter itself.211, 212 Finally, 
pressure-driven delivery demonstrated an inability to reliably direct the infusate towards a target 
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site, and is similarly not feasible for transcortical perfusions of drugs over wide surface areas.211, 
212 
Previous experiments with small-scale, localized perfusions demonstrated that the 
transport of a molecule into a porous, aqueous medium depends on the properties of the solute 
(such as its electrophoretic mobility and molecular weight and size), the ionic strength of the 
fluid used during the infusion,164 the applied electrical current, and properties outside of the 
capillary tip, such as the medium’s ζ-potential and tortuosity. A mathematical description of the 
ejection of a molecule was derived to explain the Peclet number, Pe, which indicates the relative 
contribution of convection-enhanced delivery versus diffusion alone.164 The distance scale for 
these previous experiments ranged from only a few micrometers to several hundred micrometers, 
and moreover these experiments were performed in homogenous hydrogel matrices or OHSC.164 
These penetration distances are not clinically relevant for the treatment of malignant gliomas; 
penetration distances on the order of millimeters (and most desirably, centimeters) are needed to 
achieve infusions with relevant volumes of distribution.186, 187 
The brain is a heterogeneous organ composed of not only several cell types, but also of 
varying regional architecture. From a simplistic viewpoint, the brain is divided into three primary 
regions – the cerebrum, cerebellum, and brainstem – which are further segmented based on 
function, histological appearance, and vascular distributions.213 For instance, the folded outer 2 
to 5 mm of the cerebrum contains the soma of roughly 1010 interconnected neurons, termed the 
cortex or gray matter.213 Just below the gray matter lies the white matter, comprised of the 
downward axonal projections of these neurons, which terminate in the thalamus, spinal cord, or 
other brain stem nuclei. Most malignant gliomas arise deep within this white matter near the 
natural cerebrospinal fluid-portions of the brain, termed ventricles.179 Located adjacent to the 
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ventricles are a myriad of other bilateral structures – the thalami, hypothalami, basal ganglia, 
hippocampi, and the white matter tracts which give rise to the cerebral peduncles. Each of these 
structures has different densities, arrangements of soma or axons, and ultimately may result in 
variable transport of a molecule due to heterogeneous tissue permeabilities.213 As such, in vivo 
infusions of wide areas are necessary to evaluate transport over a range of tissue architectures 
and subregions. 
While capillary tips with radius of approximately 2 μm were used in the short-distance 
perfusions in Chapter 3, this chapter utilized fused silica capillaries with a more negative ζ-
potential and larger tips with radii of 25 and 50 μm.170, 173, 214, 215 The ζ-potential of fused silica 
capillaries induce greater electroosmosis at a given electric field when compared to the 
borosilicate capillaries with a lower magnitude ζ-potential. Furthermore, a range of applied 
electrical currents was examined to deliver reproducible long-distance infusions of a small, 
cationic molecule – Ru(bpy)32+. This molecule was previously used for short-distance infusions 
due to its substantial and positive electrophoretic mobility and small size.164 This methodology 
was further developed to rapidly deliver a molecule to large surface areas from a hydrogel doped 
with a molecule of interest. Control of directional transport was also achieved from capillary tips 
over distances ranging from several hundred micrometers to more than one millimeter. Finally, 
this work culminated in an in vivo proof-of-principle in the adult rat brain, in an experiment 
designed to evaluate the volume of distributions attained by electrokinetic infusion. 
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5.2 EXPERIMENTAL 
5.2.1 Chemicals and Solutions 
Unless otherwise noted, the following materials were purchased from Sigma (St. Louis, 
MO) and used as received. Solutions were prepared with Millipore Synthesis A10 system 18 M 
purified water (Millipore, Billerica, MA). Glucose-free HEPES-buffered salt solution (GF-
HBSS) contained in mM: 143.4 NaCl, 5 HEPES, 5.4 KCl, 1.2 MgSO4, 1.2 NaH2PO4, and 2.0 
CaCl2. GF-HBSS was filtered, stored frozen, warmed to room temperature, and ultrasonicated 
for ten minutes before use. HBSS contained the same quantities as GF-HBSS with an additional 
10 mM D-(+)-glucose and underwent the same preparation and storage process. GBSS was made 
up of 27.5 mM D-(+)-glucose and filtered 2.7 mM MgSO4 supplemented Gey’s Balanced Salt 
solution. GBSS was stored in the refrigerator and warmed to 37 °C before use. Culture medium 
contained the following from Gibco (Invitrogen, Eugene, OR): 50 % Opti-MEM, 25 % heat-
inactivated Horse Serum, and 25 % Hanks’ Balanced Salt Solution, supplemented with 2 % B-27 
vitamin and 1 % D-(+)-glucose from Sigma.169 Medium was filtered, refrigerated for storage, and 
warmed to 37 °C before use. Texas Red dextran conjugate 70 kDa (TR70), Texas Red dextran 
conjugate 3 kDa (TR3), and boron-dipyrromethene dextran conjugate 10 kDa (BODIPY10) 
were obtained from Invitrogen. A 0.10 mM solution of TR70 and BODIPY10 was made in GF-
HBSS, filtered, and frozen until use. Tris(2,2’-bipyridine)ruthenium (abbreviated Ru(bpy)32+) 
from Sigma was diluted to 45 mM in GF-HBSS. The free diffusion coefficients and 
electrophoretic mobilities were determined as described in Chapters 2 and 3. 
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5.2.2 Synthesis and Characterization of Hydrogels 
A 25% weight/weight acrylic acid poly(acrylamide-co-acrylic acid) hydrogel was 
prepared with the purpose of creating a matrix with a similar ζ-potential to brain tissue by a 
thermally-initiated radical polymerization reaction, as described in Chapter 2. It was 
subsequently characterized and the ζ-potential, tortuosity, porosity, and conductivity were 
determined, as described in Chapters 2 and 3. 
5.2.3 Organotypic Hippocampal Slice Cultures (OHSC) 
The organotypic hippocampal slice culture (OHSC) method, developed by Stoppini et 
al.,92 was used with slight variations. The following procedures were approved by the University 
of Pittsburgh Institutional Animal Care and Use Committee. Bilateral dissections of the 
hippocampi were done on 9-day postnatal Sprague-Dawley albino rats. The hippocampi were 
chopped along the transverse axis to 400 μm thick slices using a McIlwain tissue chopper 
(Mickle Laboratory Engineering, Surrey, England). The slices were placed on 0.4 μm PTFE 
insert membranes (Millipore, Bedford, MA) and incubated over 1.2 mL of medium at 36.5 °C in 
5 % CO2/ 95 % air for 6 to 8 days. Culture medium was exchanged every 2 to 3 days. Prior to 
experiments, culture medium was replaced with 37 °C GBSS and incubated for thirty minutes. A 
second GBSS exchange followed for another incubation period of 30 minutes. A last exchange to 
37 °C HBSS and incubation for 30 minutes was done prior to experimental use. 
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5.2.4 Electrokinetic Infusions into Hydrogels 
Fused silica capillaries of two types: (1) 50.0 ± 0.1 μm inner diameter, 358.5 ± 1.5 μm 
outer diameter, length 10 cm and (2) 99.5 ± 0.2 μm inner diameter, 361.1 ± 0.7 μm outer 
diameter, length 10 cm (Polymicro Technologies, Phoenix, AZ) were cleanly cut to a blunt tip 
with the same dimensions. The capillary was filled with the 45 mM Ru(bpy)32+ solution. The 
PVC cell, as described in section 3.3.9, was secured on an Olympus IX-81 inverted fluorescence 
microscope stage and imaged with a high-resolution charged-coupled device camera (ORCA-
ER). 
A 25% acrylic acid poly(acrylamide-co-acrylic acid) hydrogel section was cut to size and 
carefully placed in the cell. Careful attention was made to ensure complete hydrogel contact with 
the exposed cover slip. The fused silica capillary was carefully threaded through one side of the 
channel and into the hydrogel. The distal end of the fused silica capillary was immersed in a vial 
containing GF-HBSS and a Ag working electrode. Additionally, a Ag wire ground electrode (0.3 
mm diameter) was threaded through the other side of the cell and was inserted into the hydrogel, 
so that the distance between the capillary tip and the ground electrode was always more than 5 
mm. The current source was a Princeton Applied Research 173 potentiostat (PAR) (Princeton, 
NJ). The circuitry was described previously.164 Image sequences were acquired using 
MetaMorph 7.6.2.0 software (MDS Analytical Technologies, Sunnyvale, CA) using an UPlan Fl 
4× Olympus objective lens. MetaMorph software triggered the onset and cessation of current 
during image acquisition. The potential across the system was monitored by the PAR 
potentiostat. Currents ran for up to 40 minutes, ranging from 0.2 to 1.5 μA. These experiments 
were conducted for both the ~50 μm and the ~100 μm diameter unpulled capillaries. 
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Image sequences were analyzed by drawing a line scan from approximately the center of 
the capillary tip to the end of the field of view on the same axis as the capillary lumen. Intensity 
data were recorded along the line scan before the initiation of current (background intensity), and 
at 30 seconds intervals after the current was applied. Background intensity was subtracted from 
line scan intensities. Reported intensity values are between 0 and 4,095. Values of I0 (maximum 
fluorescence intensity), I1, and Pe were determined by nonlinear fitting of Equation 5.1, similar 
as in Chapter 3, to data with Mathcad 14 (PTC, Needham, MA). I1 is included to correct for 
baseline intensity. The penetration distance in SI units of distance, r, was obtained by 
multiplying ρ by the capillary tip radius. 
I()  I0 1 e
Pe
1 ePe



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5.2.5 Infusions of a Small, Cationic Solute into OHSC 
Fused silica capillaries (99.5 ± 0.2 μm inner diameter, 361.1 ± 0.7 μm outer diameter, 
length 10 cm) (Polymicro Technologies, Phoenix, AZ) were cleanly cut to a blunt tip with the 
same diameter dimensions. The unpulled infusion capillary was filled with the 45 mM 
Ru(bpy)32+ solution. Experiments in the OHSC were secured on an Olympus IX-81 inverted 
fluorescence microscope stage and imaged with a high-resolution charged-coupled device 
camera (ORCA-ER), with the setup described by Figure 5.1. An insert membrane with an OHSC 
was placed in a glass dish without GF-HBSS underneath the insert membrane, so that the current 
path would travel through the OHSC. The infusion capillary was positioned at a 90° angle 
relative to the plane of the OHSC using a manipulator arm on a Narishige NMN-21 
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micromanipulator (Tokyo, Japan). The tip was inserted onto the CA1 region of the OHSC. The 
distal end of the fused silica capillary was immersed in a vial containing GF-HBSS and a Ag 
working electrode. The counter Ag electrode was guided into the CA3 region of the OHSC by a 
second manipulator arm on a Narishige NMN-21 micromanipulator (Tokyo, Japan). The 
electrode circuitry was also the same as the hydrogel experiment.164 The current source was the 
Princeton Applied Research 173 potentiostat (PAR) (Princeton, NJ). Image sequences were 
acquired using MetaMorph 7.6.2.0 software (MDS Analytical Technologies, Sunnyvale, CA) 
using an UPlan Fl 4× Olympus objective lens. MetaMorph software triggered the onset and 
cessation of current during image acquisition. The potential across the system was monitored by 
the PAR potentiostat. A 1.0 μA current was applied for up to 15 minutes with longer times 
causing dryness of the tissue. 
 
 
Figure 5.1. Setup for ejections of Ru(bpy)32+ into OHSC with 1.0 μA applied current. The infusion capillary is filled 
with Ru(bpy)32+ and placed in the CA1 at a 20° angle from the OHSC plane, while the counter electrode was 
inserted into CA3. 
 
In a separate experiment, the OHSC and insert membrane were placed in a glass dish 
containing GF-HBSS, filled so that the fluid level made contact with the underside of the insert 
membrane. This fluid contact with the insert membrane introduced an alternate current path, so 
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that it was no longer directed through the OHSC and instead downward through the insert 
membrane. All other experimental constraints, including the current, experiment time, and 
imaging parameters remained the same. 
5.2.6 Dual-Capillary Infusions into OHSC 
Fused silica capillaries (99.5 ± 0.2 μm inner diameter, 361.1 ± 0.7 μm outer diameter, 
length 10 cm) (Polymicro Technologies, Phoenix, AZ) were cleanly cut to a blunt tip with the 
same diameter dimensions or pulled using the Sutter P-2000 capillary puller to tips of 20 μm 
inner diameter. Tip size and shape were measured using an Olympus BX41 optical microscope. 
The pulled capillary (termed the infusion capillary) was filled with a 0.32 mM TR70 solution in 
GF-HBSS. The unpulled capillary (termed the counter capillary) was filled with GF-HBSS. The 
distal end of each capillary was placed into a vial containing GF-HBSS and an Ag electrode. The 
vial containing the infusion capillary contained the working Ag electrode, while the vial 
containing only the GF-HBSS contained the ground Ag electrode. 
Experiments in the OHSC were setup as described by Figure 5.2. An insert membrane 
with an OHSC was placed in a glass dish. The infusion capillary filled with TR70 was 
positioned at a 20° angle from the plane of the OHSC using a manipulator arm on a Narishige 
NMN-21 micromanipulator (Tokyo, Japan). The pulled capillary tip was inserted adjacent to the 
dentate gyrus of the OHSC. The counter capillary was positioned at a 90° angle from the plane of 
the OHSC using a second manipulator arm on a Narishige NMN-21 micromanipulator (Tokyo, 
Japan). The unpulled counter capillary was inserted near the interface of CA1 and CA3 of the 
OHSC, so that the distance between the two capillaries was approximately 350 μm. 
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Figure 5.2. Dual-capillary ejection of TR70 into OHSC with 0.3 μA applied current. The infusion capillary is filled 
with TR70 and placed adjacent to the dentate gyrus at a 20° angle from the OHSC plane, while the counter capillary 
was filled with GF-HBSS and positioned between CA3 and CA1 at a 90° angle from the OHSC plane. 
 
The current source was a Princeton Applied Research 173 potentiostat (PAR) (Princeton, 
NJ), attached to the secured electrodes as described previously.164 The entire setup was 
positioned in a glass dish over the objective lens of an Olympus IX-81 inverted fluorescence 
microscope. Image sequences were acquired using MetaMorph 7.6.2.0 software (MDS 
Analytical Technologies, Sunnyvale, CA) using an UPlan Fl 4× Olympus objective lens. 
MetaMorph software triggered the onset and cessation of current during image acquisition. The 
potential across the system was monitored by the PAR potentiostat. A 0.3 μA current was 
applied for 20 minutes. 
5.2.7 Doped Hydrogel Infusions into OHSC 
A 25% acrylic acid poly(acrylamide-co-acrylic acid) hydrogel was placed in a solution of 
0.5 mM TR3 in GF-HBSS, and allowed to equilibrate overnight. The doped hydrogel was 
removed from the solution and cut to a size of 3 mm × 3 mm at the base × 2 mm high. The 
hydrogel was placed over the subiculum and entorhinal cortex portions of an OHSC on its 
culture insert membrane. A second 25% acrylic acid poly(acrylamide-co-acrylic acid) hydrogel 
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that did not contain fluorophore (only GF-HBSS) was placed over the opposite border of the 
OHSC, just adjacent to the CA3 region. The distance between the doped and counter hydrogels 
was 1.5 mm. Two Ag wires with 0.3 mm diameter were each placed into the hydrogels. The 
Digital MidgardTM Precision Current Source iontophoretic pump (Stoelting Co., Wood Dale, IL) 
was used as the current source, attached to the secured electrodes as described previously.164 The 
entire setup was positioned in a glass dish over the objective lens of an Olympus IX-81 inverted 
fluorescence microscope. No buffer solution was below the OHSC and insert membrane, again 
to direct the current flow through the OHSC. This setup is shown in Figure 5.3. 
 
 
Figure 5.3. Experimental setup for the doped hydrogel perfusion of TR3 through OHSC with 10.0 μA applied 
current, viewed from the side. Two hydrogels are spaced by 1.5 mm over the OHSC. In the control experiment, the 
counter electrode is not placed into the hydrogel, and is instead placed remotely. 
 
Image sequences were acquired using MetaMorph 7.6.2.0 software (MDS Analytical 
Technologies, Sunnyvale, CA) using an UPlan Fl 4× Olympus objective lens. TR3 was imaged 
using a 560/25 excitation filter, a 625/26 emission filter, both obtained from Olympus, and the 
Semrock triple-band dichroic mirror described earlier, with intensity values between 0 and 4,095. 
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An image was acquired every 30 seconds. MetaMorph software triggered the onset and cessation 
of current during image acquisition. The potential across the system was monitored by the 
MidgardTM pump. A 10.0 μA current was applied for 12 minutes. However, after 10 minutes, the 
insert membrane began to dry out and the imaging was obscured. As a result, the data is 
presented up to 10 minutes. 
In a separate experiment, the OHSC and insert membrane were placed in a glass dish 
containing GF-HBSS, filled so that the fluid level made contact with the underside of the insert 
membrane. The fluid contact with the insert membrane introduced an alternate current path, so 
that it was no longer directed through the tissue and instead downward through the insert 
membrane. The working and counter electrodes were still placed in the doped and counter 
hydrogels respectively. All other experimental constraints, including the current, experiment 
time, and imaging parameters remained the same. 
5.2.8 Electrokinetic Infusions In Vivo 
The following procedures were approved by the University of Pittsburgh Institutional 
Animal Care and Use Committee. Male Sprague-Dawley rats (Hilltop, Scottsdale, PA), with 
weights ranging from 260 to 290 g, were anesthetized with isoflurane, and wrapped in a 37 °C 
homoeothermic blanket (EKEG Electronics, Vancouver, BC, Canada). An incisor bar was set at 
0 mm at the interaural line. Rats underwent aseptic stereotactic surgery, whereby bilateral 
craniotomies were made to position an infusion capillary and counter capillary into the thalami 
bilaterally (from bregma: 4.0 mm lateral, 1.3 mm posterior, and 5.0 mm below the dura) for 
volumetric analysis. The capillaries were also implanted into the hippocampi bilaterally (from 
bregma: 4.0 mm lateral, 1.3 mm posterior, and 2.5 mm below the dura). 
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 Fused silica capillaries (99.5 ± 0.2 μm inner diameter, 361.1 ± 0.7 μm outer diameter, 
length 15 cm) (Polymicro Technologies, Phoenix, AZ) were cleanly cut to a blunt tip with the 
same diameter dimensions, and were used as the two implanted capillaries. The infusion 
capillary was filled with the fluorophore solution of interest: a 45 mM solution of Ru(bpy)32+ in 
GF-HBSS or a co-solution of 0.1 mM TR70 and 0.1 mM BODIPY10 in GF-HBSS were used. 
The counter capillary was filled with GF-HBSS. The distal ends of the fused silica capillaries 
were immersed into a vial containing the same fluorophore solution or GF-HBSS for the infusion 
and counter capillaries respectively. Ag wire electrodes were inserted into each of these vials and 
connected to the Digital MidgardTM Precision Current Source iontophoretic pump (Stoelting Co., 
Wood Dale, IL). A current of 25.0 μA was applied for 45 minutes. For experiments that 
evaluated diffusional transport, the same setup was used but no current was applied. 
After the electrokinetic infusion period, the rats underwent rapid transcardial perfusion 
with 250 mL of 8% cold paraformaldehyde in PBS. The brain was immediately isolated, 
sectioned into 4 mm coronal slices, and then further sectioned on a vibratome into 300 μm thick 
coronal slices. Vibratome sectioning was quantitative, with no discarded tissue between slices 
with a visible fluorophore spot. The time required for the transcardial perfusion and vibratome 
sectioning was less than 30 minutes, while the transcardial perfusion itself was completed in less 
than 5 minutes. The 300 μm thick coronal slices were mounted onto glass slides and imaged with 
the Olympus IX-81 inverted fluorescence microscope. Image sequences were acquired using 
MetaMorph 7.6.2.0 software (MDS Analytical Technologies, Sunnyvale, CA) using a PlanApo 
1.25× Olympus objective lens and Olympus filters. TR70 was imaged using a 555/25 excitation 
filter and a 605/52 emission filter. BODIPY10 was imaged using a 490/20 excitation filter and a 
525/36 emission filter. Ru(bpy)32+ was imaged using a 460-490 excitation filter and a 605/52 
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emission filter. The fluorescence intensity values were between 0 and 4,095. Slices were cryo-
protected and stored at -20 °C until further use. 
The volumes of distribution from the infusions were determined by evaluating the 
fluorescence intensities amongst the coronal tissue slices. The overall maximum fluorescence 
intensity (I0) at the infusion capillary implantation site was determined for each rat. The distance 
along eight radii was measured from a central point of maximum fluorescence intensity (in that 
slice) to the point where the fluorescence intensity was 25% of I0. The eight radii were averaged 
together to arrive at a radius to determine the area of tissue impacted by the infusions, assuming 
a circular area. The coronal area within each slice was multiplied by the thickness of the slice to 
arrive at a volume per tissue slice. The volumes of each slice were summed to arrive at a final 
volume of distribution for each rat and fluorophore. 
5.3 RESULTS AND DISCUSSION 
5.3.1 Effect of Capillary Tip Size and Current on Infusions 
Using fused silica capillaries and the poly(acrylamide-co-acrylic acid) hydrogel model 
for brain tissue, the effect of capillary tip diameter on the infusion profile and penetration 
distance was evaluated. The capillary tip diameters evaluated were approximately 50 and 100 
μm. A small dicationic fluorescent molecule (Ru(bpy)32+, MW 570) was infused from each 
capillary for up to 40 minutes, with results shown in Figure 5.4. As expected, further penetration 
distances were achieved in comparison to the roughly 4 μm diameter tips employed in Chapter 3, 
with the penetration distance where the fluorescence intensity was 25% of I0 occurring at 4,516 ± 
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112 μm (N = 5) away from the 100 μm diameter capillary tip and at 1,489 ± 27 μm (N = 5) away 
from the 50 μm diameter capillary tip, both at 1.0 μA (data are presented as means ± SEM). 
There was only an approximately 2% error in the penetration distances, indicating the highly 
reproducible nature of the infusion profile. In comparison to the work presented in Chapter 3, the 
dimensionless distance, ρ, was no longer needed to normalize penetration distances for variations 
in capillary tip size because the 50 and 100 μm diameter tips were unpulled, cut to a blunt tip, 
and were reproducible size. As such, the penetration distance data in Figure 5.4 is presented in SI 
units of micrometers. 
 
Figure 5.4. Effect of capillary tip size on penetration distance (μm) from 1 μA infusions for 40 min of Ru(bpy)32+ in 
a hydrogel with -24.7 mV ζ-potential: square, 50 μm diameter tip (N = 5), diamond, 100 μm diameter tip (N = 5). 
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The expression for the diffusional concentration distribution (directly related to the 
fluorescence intensity profile) of a molecule at steady-state is provided by Equation 5.2, where r 
is the distance from the hemispherical source and a is the radius of the hemispherical source.168 
C(r)  C(a) a
r
 
5.2 
It is noteworthy that the diffusion coefficient does not influence the ultimate distribution of a 
molecule, rather only the time needed to reach steady-state. Since the fluorescence intensity is 
directly related to the concentration of the fluorophore, 25% of I0 may be expressed as C(r)/C(a) 
equal to 0.25. The penetration distance achievable by diffusion alone is r=4a. For a 50 μm 
diameter capillary tip, this corresponds to a penetration distance of roughly 100 μm. For a 100 
μm diameter capillary tip, this corresponds to a penetration distance of roughly 200 μm. 
Therefore, a ratio of the penetration distance at 25% of I0 of the electrokinetic transport of 
Ru(bpy)32+ to diffusion alone at 40 minutes was calculated as 22 and 15 for the 100 μm and 50 
μm diameter capillary tips respectively. 
The infusions can also be evaluated in terms of Pe, obtained from fitting the experimental 
fluorescence intensity versus distance data to Equation 5.1. Equation 5.1 was derived for the 
steady-state condition, as discussed in Chapter 3, but it was applied to this data set because it had 
been previously validated for small capillary tips and not due to a belief that 40 minute infusions 
achieved steady-state. In fact, the time to steady-state should scale linearly with the capillary tip 
diameter. For instance, the time to steady-state for 1.0 μA ejections of TR70 from an 
approximately 4 μm capillary tip diameter into a -24.7 mV ζ-potential hydrogel was estimated as 
1,610 seconds (~27 minutes) in Chapter 3, and therefore the time to steady-state would take 
roughly 20,125 seconds (~335 minutes) for similar infusions from a 50 μm diameter capillary 
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tip. Nonetheless, fitting the intensity versus distance data to Equation 5.1 yielded R2 greater than 
0.98 in all instances. A plot of the experimentally derived Pe versus time are provided in Figure 
5.5. 
 
Figure 5.5. Effect of applied current on Pe over time (min) for Ru(bpy)32+ from a 50 μm diameter capillary tip in a 
hydrogel with -24.7 mV ζ-potential: circle, 0.2 μA (N = 5), triangle, 0.5 μA (N = 5), square, 1.0 μA (N = 5), 
diamond, 1.5 μA (N = 5). 
 
The Pe demonstrated a time-dependent increase over the range of currents from 0.2 to 1.5 
μA. With the lowest current (0.2 μA), Pe began to approach its limit after around 40 minutes, 
while Pe continued to increase with higher currents during the same timeframe. Based on data 
from Chapter 3 and Equation 5.2, the time to steady state for 0.2 μA infusions from a 50 μm 
diameter capillary tip should take roughly 6,150 seconds (~103 minutes). Furthermore, the Pe 
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should not vary during steady-state infusions of a molecule from a capillary tip. Clearly there 
was variability of Pe over time with a particular capillary tip size from 0.2 to 1.5 μA, indicating 
the infusions were not actually at steady-state. The time to reach constant Pe may be considered 
as an indirect indicator of the time to reach steady-state. Of note, lower applied currents seemed 
to be reaching constant Pe (and thus steady-state) faster than with higher applied currents. This 
result is consistent with the data presented in Chapter 3 for short-distance ejections. 
With a particular capillary tip size (~50 μm diameter) and the same Ru(bpy)32+ infusate, 
experimental time, and hydrogel conditions, only the applied electrical current was varied. As 
shown in Figure 5.6, the penetration distance increased predictably over a range of currents from 
0.5 to 1.5 μA, for percentages of I0 equal to 75%, 50%, and 25%. Over this narrow range of 
applied currents, the distances where 25% of I0 occurred at 1,342 ± 67 μm (N = 5) away from the 
capillary tip and 1,682 ± 36 μm (N = 5) away from the capillary tip after 40 minutes of infusion 
for 0.5 and 1.5 μA currents respectively. Furthermore, there was only an approximately 2 to 5% 
error in the penetration distances, indicating the highly reproducible nature of the infusions. The 
ratio of the penetration distance at 25% of I0 of the electrokinetic transport of Ru(bpy)32+ to 
diffusion alone was 14 and 17 for the 0.5 and 1.5 μA currents respectively. Thus, increasing the 
applied electrical current resulted in greater perfusion distances. 
Finally, Figure 5.7 shows the current-dependent change in maximum fluorescence 
intensity (I0) of Ru(bpy)32+ after 40 minutes of infusion using varying applied electrical currents. 
With increasing current from 0.2 to 1.5 μA, the fluorescence intensity just outside of the 
capillary tip began to approach its limit. At higher currents (i.e.: 1.5 μA), the fluorescence 
intensity outside of the tip started to approximate the fluorescence intensity within the capillary 
itself. 
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Figure 5.6. Effect on penetration distance (μm) with varying current from 50 μm capillary tip infusions for 40 min 
of Ru(bpy)32+ in a hydrogel with -24.7 mV ζ-potential: triangle, 0.5 μA (N = 5), square, 1.0 μA (N = 5), diamond, 
1.5 μA (N = 5). 
 
It should be noted that these experiments all utilized a small, highly charged molecule, 
Ru(bpy)32+, as the electrokinetic infusate. This molecule was selected because it has an 
appreciably positive electrophoretic mobility, and was therefore expected to strongly interact 
with the applied electric field. As such, the electrophoretic and electroosmotic velocity vectors 
were aligned, with resulting enhancement of electrokinetic transport. As discussed in Chapter 1 
and elucidated in subsequent chapters, electrokinetic transport is fastest when the electroosmotic 
and electrophoretic vectors are aligned, as in the case of Ru(bpy)32+. In the case of a neutral 
molecule of similar size, the electroosmotic velocity vector is the primary motivating force 
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behind transport and the molecule would travel a shorter distance since there is no contribution 
from electrophoresis. Finally, for negatively charged molecules of a similar size, the 
electrophoretic and electroosmotic velocity vectors are opposed to one another, and consequently 
the rate of transport would be even less (if it all). With the significant ζ-potential of fused silica 
capillaries,170, 173, 214, 215 the molecules used in previous chapters – TR70, FL70, TR3, and 
Ru(bpy)32+ – all may be ejected. However, the rate of transport away from the capillary is based 
upon molecular weight and electrophoretic mobilities, Ru(bpy)32+ is expected to travel furthest in 
a given time, followed by TR3, then TR70, and finally FL70. 
 
Figure 5.7. Effect of applied current on the maximum fluorescence intensity (I0) for Ru(bpy)32+ infusions from a 50 μm capillary tip in a hydrogel with -24.7 mV ζ-potential. Data taken after 40 minutes of ejection, N = 5 each data 
point. 
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5.3.2 Electrokinetic Transport Determined by Current Path 
Pressure-driven delivery of molecules in clinical trials elucidated several complications 
related to controlling the direction of fluid flow.195, 202, 203, 205-212 In these trials, infusions 
followed paths of least pressure resistance (which did not usually coincide with their target path), 
and often penetrated ependymal linings with uncontrolled ejections into the ventricular system, 
flowed backwards along the infusion cannula, or deformed the brain tissue itself. Electrokinetic 
transport utilizes the path of current flow, as demonstrated from prior work with 2 μm 
borosilicate capillary tips.164 Building from this work, a greater control of transport over wider 
tissue areas is necessary for clinical applications. For example, placement of a counter-electrode 
within a tumor may direct the flow of a molecule towards the tumor interior. 
To test this hypothesis, the ability to control the directional path of capillary infusions 
with counter-electrode placement was examined. Figure 5.8 shows dramatic bending of a 
fluorophore’s path over more than 400 μm, as a TR70 solution in GF-HBSS was infused from an 
approximately 20 μm diameter capillary tip positioned at the dorsal tip of the dentate gyrus 
towards an unpulled 100 μm diameter counter capillary placed at the interface between CA1 and 
CA3 in an OHSC, as described in Figure 5.2. In this example, TR70 was transported along a 
current path towards the counter capillary, with no backflow along the infusion capillary. 
Moreover, because TR70 had an essentially zero electrophoretic mobility, this anisotropic 
transport was predominantly due to electroosmosis. As with the ejections of TR70 into OHSC 
presented in Chapter 3, a roughly spherical infusion profile was seen if the counter electrode was 
placed remotely. The ejection shown in Figure 5.8 is unique because of the dramatic bending 
towards the counter capillary, which cannot be a result of diffusion. 
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To quantify this ejection, a series of three regions of interest were identified to determine 
the average fluorescence intensities at the initiation and cessation of electrical current 
application. One region was drawn over the lumen of the counter capillary 420 μm away from 
the injection capillary tip (Region 1), a second was 420 μm away from the injection capillary tip 
(Region 2), and a third was drawn remotely (1,025 μm from counter capillary) to determine the 
background fluorescence (Region 3). The background-corrected average fluorescence intensities 
were 50.1 (range: 5 to 100) and 26.5 (range: 19 to 29) for Regions 1 and 2 respectively prior to 
the initiation of the electrical current. After a 0.3 μA current was applied for 20 minutes, the 
background-corrected average fluorescence intensities were 148.7 (range: 64 to 224) and 13.4 
(range: 12 to 23) for Regions 1 and 2 respectively. Anisotropic transport of TR70 towards the 
counter capillary is not possible by diffusion. 
 
 
Figure 5.8. Dual capillary experiment in OHSC with 0.3 μA of applied current. The pulled 20 μm diameter infusion 
capillary is filled with TR70 and inserted at the dorsal tip of the dentate gyrus at a 20° angle to the OHSC surface. 
The 100 μm diameter unpulled counter capillary is filled with GF-HBSS and inserted approximately 420 μm away 
at the interface between CA1 and CA3 at a 90° angle to the OHSC surface. The left panel was at the start of the 
experiment and the right panel is following 20 minutes of applied current. The fluorescence intensities were 
determined in each region of interest, denoted by the white circles. The green scale bar is 350 μm.  
 
A defined current path affords greater control of electrokinetic infusion and addresses a 
key limitation of pressure-infusion borne out through clinical trials.211, 212 The counter capillary 
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may not be positioned at any distance away from the infusion capillary, however. The electric 
field away from a point source is proportional to 1⁄r2 (where r is the distance away), and 
therefore decays rapidly from the capillary tip. It is reasonable to conclude that electrokinetic 
transport cannot occur when the electric field becomes zero, and as the electric field diminishes 
at further distances, the rate of transport decreases. 
In a second example shown in Figure 5.9, the counter capillary was replaced with an Ag 
wire (0.3 mm diameter) as the counter electrode and inserted into CA3 of an OHSC. The 20 μm 
pulled infusion capillary was replaced with an 100 μm unpulled infusion capillary filled with a 
45 mM Ru(bpy)32+ solution in GF-HBSS. The infusion capillary was inserted onto CA1 
perpendicular to the plane of the OHSC. This setup was shown in Figure 5.1. As the diameter of 
the infusion capillary tip was significantly increased in this example, the corresponding electric 
field emanating from the tip was expected to remain appreciable at much further distances in the 
OHSC. Three linescans were drawn in Figure 5.9, shown as bold white lines to quantify the 
fluorescence intensity through the same drawn planes. Figure 5.9 shows the infusion of 
Ru(bpy)32+, with a bent path towards the counter electrode and increased fluorescence within the 
OHSC, after 25 minutes of applied 1.5 μA current with no GF-HBSS below the insert 
membrane. 
To direct the electrical current away from the OHSC, the counter electrode was placed 
remotely and immersed in GF-HBSS beneath the insert membrane. Under these conditions, the 
preferential transport of Ru(bpy)32+ through the OHSC was abolished, and the fluorescence was 
instead localized around the capillary tip in an approximately isotropic manner, with a 
diminished fluorescence intensity within the OHSC.  
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Figure 5.9. Single capillary experiment in OHSC with 1.5 μA of applied current for 25 minutes. The unpulled 100 
μm diameter infusion capillary was filled with Ru(bpy)32+ and inserted onto CA1 at a 90° angle to the OHSC 
surface. The Ag counter electrode was inserted approximately 1 mm away into CA3 (bottom panel) or remotely in 
GF-HBSS beneath the insert membrane (top panel). The fluorescence intensity linescans on the far right represent 
the white horizontal lines drawn across the middle two panels, with those for the top panel above those of the bottom 
panel. The green scale bar is 500 μm. 
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Linescan 1 represented the horizontal plane across the imaging field, located 350 μm 
away from the infusion capillary. Linescan 2 represented the perpendicular plane 600 μm 
between the infusion capillary and counter electrode. Linescan 3 represented a mirrored plane of 
linescan 2 that was 600 μm away from the infusion capillary. There was considerably more 
fluorescence across the linescans when the current was directed through the OHSC, as compared 
to the control experiment. Linescan 1 revealed an almost two-fold increase in the fluorescence 
intensity when the current path was directed through the OHSC. In linescan, 2 the lower 
distances describe the region nearest the infusion capillary, while the larger distances describe 
the same region in linescan 3. When the current was not passed through the OHSC due to the 
introduction of GF-HBSS below the insert membrane, the maximum fluorescence intensity 
occurred at roughly 380 and 1,015 μm on linescans 1 and 2 respectively. In contrast, the 
maximum fluorescence intensity occurred at approximately 710 and 390 μm on linescans 1 and 2 
respectively when the current was passed through the OHSC. This indicates that the maximum 
intensity passing through the linescan planes was further from the region of the infusion capillary 
when the current path was directed through the OHSC. Thus, Figure 5.9 further demonstrates the 
potential for controlled electrokinetic transport, whereby the current path may dictate molecular 
transport. 
5.3.3 Infusion from a Doped Hydrogel 
Because of issues with backflow and lack of directional control with pressure-driven 
infusion, only deep areas of the brain may be targeted. One can intuitively imagine that surface 
ejections using pressure would cause the infusate to spread across the cortical surface without 
deep penetration. To address this limitation with electrokinetic delivery, a hydrogel with a ζ-
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potential similar to brain tissue (OHSC) was used as a flexible infusion pad to deliver a 
fluorophore over wide areas, with the experimental setup described in Figure 5.3. Figure 5.10 
shows the hydrogel doped with TR3 placed over the subiculum and entorhinal cortex at one end 
of an OHSC. A second undoped, non-fluorescent hydrogel was placed on the other edge of the 
OHSC over the edge of CA3. The distance between the two hydrogels was 1,500 μm. A Ag 
electrode was inserted into each hydrogel, with current flow from the doped hydrogel through 
the OHSC towards the non-fluorescent hydrogel. 
 
 
Figure 5.10. Doped hydrogel infusion of TR3 through OHSC after 10 minutes of a 10.0 μA of applied current. The 
Ag counter electrode was inserted into a non-fluorescent hydrogel over the opposite edge of the OHSC, approximately 
1.5 mm away. When GF-HBSS was in contact with the insert membrane (top panel), the current path was different 
than without GF-HBSS below the insert membrane (bottom panel). The fluorescence intensity linescans on the far 
right represent the white horizontal lines drawn across the middle two panels. The green scale bar is 500 μm. 
 
With an applied current of 10.0 μA, TR3 was transported across the entire OHSC 
(distance ~1,500 μm) over a period of 10 minutes. Though current was actually applied for 12 
minutes, the insert membrane began to dry out after 10 minutes resulting in obscured imaging for 
 108 
the remaining two minutes. When the current path was directed away from the OHSC (and 
instead was directed through the insert membrane to the GF-HBSS underneath), diminished 
electrokinetic transport across the OHSC was observed. 
The horizontal linescans provided quantification of the TR3 fluorescence intensity 
passing through the OHSC. When the current path passed through the OHSC, the linescan 
revealed the penetration distance at 25% of I0 to be approximately 1,260 μm away from the 
doped hydrogel, almost fully across the distance between the two hydrogels. In contrast, when 
the current was directed away from the OHSC, and instead through the insert membrane to the 
GF-HBSS below, the penetration distance at 25% of I0 occurred at nearly 320 μm away from the 
doped hydrogel. Similar to the results presented in section 5.3.2, the electrical current path may 
be used to control the path of electrokinetic transport. 
This experiment also provided evidence that larger tissue areas may be impacted by 
doped hydrogel infusions, in a faster time and at higher currents, than by capillary infusions. This 
is partly due to a striking difference in the decay of the electric field within the OHSC. A 
hemispherical point source for the electric field can no longer be assumed for doped hydrogel 
infusions. Instead, the electric field between the two hydrogels can be better approximated by the 
electric field between two conducting plates. If the plates are of infinite in size, the electric field 
between the plates is constant and does not decay. Furthermore, the distance between the 
conducting plates determines the magnitude of the electric field. As the dimensions of the bases 
of the doped and counter hydrogels were larger than the OHSC, the electric field was roughly 
constant throughout the OHSC between the hydrogels (assuming negligible edge effects due to 
the hydrogels not actually being “infinite” in size). 
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Of note, the doped infusion hydrogel became dehydrated after the application of 10.0 μA 
of current, with transfer of the fluid (and TR3) into the OHSC and towards the counter hydrogel. 
This result indicated that molecules may be delivered to the cortical surface or a resection bed 
using electroosmosis, a feat not achievable with pressure-driven delivery. 
5.3.4 Electrokinetic Ejections In Vivo 
In section 5.3.1, the transport properties of various molecules were predicted from 
electrophoretic mobilities and molecular weights. Three molecules of varying molecular weight 
and electrophoretic mobilities were utilized for in vivo infusions. BODIPY10 and TR70 were 
selected because of their dissimilar molecular weights, their ability to be resolved 
spectroscopically, and their small electrophoretic mobilities, as shown in Table 5.1. Therefore, a 
difference between the volumes of tissue impacted by these two fluorescent dextran conjugates 
was predominantly due to the molecular weight difference. The small, cationic molecule – 
Ru(bpy)32+ – was expected to travel a much further distance than BODIPY10 or TR70 during a 
particular infusion time because of its relatively small molecular weight and dicationic nature 
(positive electrophoretic mobility). 
 
Table 5.1. Comparison of molecules used during in vivo infusions and their volumes of distribution (Vd). 
Infusate Molecular Weight Electrophoretic Mobility (μep) (10-9 m2/Vs) 
Vd at 25% of I0 
(μL) 
TR70 70,000 0.46 ± 0.03 (N = 3) 
0.60 ± 0.04 
(N = 3) 
BODIPY10 10,000 -0.89 ± 0.22
21 
(N = 3) 
1.71 ± 0.12 
(N = 3) 
Ru(bpy)32+ 570 
25.86 ± 0.02 
(N = 3) 
13.0 ± 2.0 
(N = 4) 
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Infusion of the three molecules was completed by stereotactic placement of two 100 μm 
diameter fused silica capillaries into the thalami of rat brains. The infusion capillary contained 
the fluorophore in a GF-HBSS solution, whereas the counter capillary contained only GF-HBSS. 
As shown in Figure 5.11 for the infusion of Ru(bpy)32+, the volume of distribution may be 
quantitatively determined by determining the infusion area within each slice, multiplying by the 
slice thickness (300 μm), and finally by summing together the volumes of the individual slices. 
The trajectory of the infusion capillary is clearly observed in Figure 5.11. One of the 
experimental runs for the co-infusion of TR70 and BODIPY10 was excluded because the 
capillary slipped during the infusion, and was consequently spread over a significantly larger 
volume and was a clear outlier. 
 
 
Figure 5.11. Typical in vivo ejection of Ru(bpy)32+ into the rat thalamus with 25.0 μA of applied current for 45 
minutes. Fluorescence was overlaid upon bright field images, and presented left-to-right from anterior (top left) to 
posterior (bottom right). The green scale bar is 1,000 μm. 
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With this volumetric analysis method, it was critical to quantitatively section the tissue 
without discarding tissue in the region where there is fluorescence. This was achieved by 
transcardial perfusion and rapid fixation of the tissue with an 8% paraformaldehyde, followed by 
vibratome sectioning, and imaging. This method for tissue preparation typically was completed 
in less than 30 minutes. Discrete, well-delineated fluorescence spots were visible more than three 
days after tissue fixation with unchanged spot sizes. Thus, negligible diffusion of the molecules 
beyond the region attained by electrokinetic transport occurred during the 30 minutes required 
for tissue preparation period, as the transcardial perfusion was completed less than five minutes 
after termination of the electrical current. 
As described in Table 5.1, the volumes of distribution (Vd) for the three molecules at 25% 
of I0 were obtained with good reproducibility (data presented as means ± standard error of the 
mean). The largest molecule evaluated, TR70, had a molecular weight of 70,000 and a roughly 
zero electrophoretic mobility. The Vd of TR70 fluorescence was determined as 0.60 ± 0.04 μL (N 
= 3). BODIPY10 had a molecular weight of 10,000 and also demonstrated a roughly zero 
electrophoretic mobility. The Vd of BODIPY10 fluorescence was determined as 1.71 ± 0.12 μL 
(N = 3). Finally, Ru(bpy)32+ was the smallest molecule evaluated, with a molecular weight of 
roughly 570, though its electrophoretic mobility was significant and positive as a result of its 
dicationic nature. The Vd of Ru(bpy)32+ fluorescence was determined as 13.0 ± 2.0 μL (N = 4). 
To control for diffusional transport from the capillary tip, an identical 100 μm diameter 
fused silica capillary was filled with the fluorophore solution and implanted into the rat thalamus 
for 45 minutes with no applied current. Immediately following this time period, the rat was 
perfused transcardially and 300 μm slices were obtained, as described earlier. For TR70, 
 112 
BODIPY10, and Ru(bpy)32+, no fluorescence was observed in the brain tissue around the 
capillary implantation site. 
The error in Vd presented in Table 5.1 ranged from roughly 5 to 15%. Moreover, the 
shape of the ejection spot was only sometimes circular, and therefore approximating the area 
within a slice as πr2 may not be accurate in all instances. To arrive at the value of r, eight 
different radii were measured at 45° intervals and averaged together. The center of each spot, 
from which the radii are drawn, was determined by locating the maximal fluorescence intensity. 
Finally, the location of the capillary implantation site was slightly variable between rats. Though 
injections occurred in the thalamus in all instances, there was some variability in the depth, due 
to differences in rat weight. If the capillary was implanted near the tissue edge of the thalamus, 
the radius along a particular measurement direction may theoretically be truncated with a 
consequently smaller area. The percent error of the volume distribution was highest for 
Ru(bpy)32+, which most readily encountered the tissue margins due to its large ejection areas. 
Thus, this final point is thought to play a role in the measurement error. 
Of particular interest, the tortuosity – and in particular the frictional drag force – also 
determined the penetration distance (and Vd) a molecule achieved in a given time span. The 
frictional drag force generated by the tissue for the three molecules was likely not the same. As 
presented in Chapter 1, this drag force includes steric effects, reptation and entropic barrier 
transport of linear, flexible molecules, changes in the diameter of channels in the extracellular 
space during non-homeostatic conditions, anisotropy of the tissue architecture, clearance of a 
molecule from the extracellular space, and any biochemical reactions that may occur in the tissue 
itself. 
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Through this dissertation and others, it has been determined that the tortuosity is larger 
with increasing molecular weight in brain tissue,59 and this effect is likely due to steric effects, 
reptation, entropic barrier transport, and the diameter of channels in the brain extracellular space. 
The tortuosity for a 70 kDa dextran conjugate in cortical slices from rats was found to be 2.25 ± 
0.09, whereas this value was only 1.63 ± 0.05 for a 10 kDa dextran conjugate.59 Furthermore, the 
fluorescent dextran conjugates used in these experiments do not show affinity for cellular 
membranes or reactivity in the extracellular matrix.21 The rate of fluid clearance from the given 
volume of brain tissue in vivo (such as for fluid introduced by an infusion) ranges from 
approximately 0.3 to 0.5 μL min-1 mL-1.89 For an adult rat brain, with a volume on the order of 
1.75 mL, this corresponds to a clearance rate of roughly 0.53 to 0.88 μL/min. This clearance rate 
was appreciable with respect to the volume of solution introduced into the rat brains (Vi) during 
infusions. 
The Vi was estimated by determining the electroosmotic velocity through the capillary tip 
multiplied by the area of the capillary tip. To determine the electroosmotic velocity, the ζ-
potential of the brain tissue was estimated to be approximately -22.8 mV.22 The flow rate 
through a 100 μm fused silica capillary with a current of 25.0 μA was therefore 0.016 μL/min. 
Thus, over 45 minutes, approximately 0.72 μL of the fluorophore solution was introduced into 
the thalamus. 
 Estimating the electrokinetic flow rate was not trivial, especially at the interface of two 
media with varying ζ-potentials. In the absence of a ζ-potential mismatch, the flow rate would be 
calculated with the ζ-potential of fused silica, and would be higher (approximately 0.04 μL/min). 
The ζ-potential of the fused silica capillary was estimated to range from approximately -50 to -60 
mV,173 while the ζ-potential of the OHSC was assumed to be -22.8 mV,22 and provided a 
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reasonable estimation for the thalamus. Thus, a ζ-potential mismatch did occur, with the 
development of positive-pressure just outside of the capillary tip.20, 174 However, no visible tissue 
deformation due to increased pressure was observed at the capillary implantation site. Therefore, 
the pressure outside of the capillary tip likely decreased the flow rate from the capillary instead. 
Using the ζ-potential of the brain tissue provided a conservative estimate of the electrokinetic 
flow rate. 
To compare the electrokinetic Vd to those obtained by pressure-driven infusion, whereby 
the volume of distribution was estimated at a distance of more than 15% of the concentration of 
the infusion solution,195 the electrokinetic Vd must be translated to distances of 15% rather than 
25% of I0. Due to fluorescence signal to noise issues at such low intensities, especially for TR70, 
this was not determined experimentally. Instead, this may be accomplished by Equation 5.3, 
assuming a spherical ejection. 
Volume15% "Edge"  0.850.75




3
  Volume25% "Edge" 5.3
Therefore, the Vd at 15% of I0 were 0.87 ± 0.06 μL for TR70 (N = 3), 2.49 ± 0.18 μL for 
BODIPY10 (N = 3), and 18.88 ± 2.85 μL for Ru(bpy)32+ (N = 4). 
According to Chen et al., the resulting Vd of radiolabeled albumin (MW 69 kDa) was 
20.8 ± 2.10 μL, assuming an infusion volume of only 4.0 μL into the rat striatum with a 0.5 
μL/min flow rate.195 This resulted in a ratio of the Vd to Vi of 5.2 ± 0.5. With this flow rate, a 
roughly 5% leakage was observed, and at higher flow rates (1.0 μL/min) the leakage exceeded 
20%.195 In contrast, electrokinetic infusion of TR70 (MW 70 kDa) using a 100 μm fused silica 
capillary with a current of 25.0 μA resulted in a Vd of 0.87 ± 0.06 μL and a Vi of 0.72 μL. 
Therefore, the ratio of the Vd to Vi for TR70 was 1.2 ± 0.1. The ratios of the volume of 
distribution to the volume of infusion for BODIPY10 and Ru(bpy)32+ were 3.5 ± 0.3 and 26.2 ± 
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4.0 respectively. The ratio for TR70 was lower, yet comparable, to pressure-driven infusion in 
the rat brain.195 While a 0.5 μL/min flow rate represented the highest flow rate without 
substantial backflow, the data for albumin by pressure-driven infusion represented a maximum 
Vd to Vi in brain tissue. In contrast, the electrokinetic flow rate of 0.016 μL/min was limited only 
by the available electronic equipment and not by the brain tissue. In contrast, Vd to Vi ratio was 
determined as 13:1 for radiolabeled sucrose (MW 359) in the cat brain to the 1% isodose,194 
though this may have been limited by the volume of brain tissue itself. If Equation 5.3 was 
calculated to the 1% edge for a comparably-sized molecule – Ru(bpy)32+ – then the Vd to Vi ratio 
was roughly 41:1. 
The current density for a 100 μm diameter capillary tip with 25.0 μA of applied current, 
as utilized in vivo, was 3,180 A/m2 at the tip. In contrast, the current density for 0.5 μA ejections 
from an approximately 4 μm diameter capillary tip, as utilized in Chapter 3 for OHSC ejections, 
was 39,790 A/m2 at the tip. No appreciable cell death, as evident by propidium iodide staining, 
was visible at this current density in OHSC.164 Finally, electroporation from a 2 μm diameter 
capillary tip with a typical current of 0.125 μA also yielded a current density of 39,790 A/m2 at 
the tip.216 To achieve higher, yet “safe,” current densities similar to the OHSC or electroporation 
conditions for in vivo ejections from a 100 μm diameter capillary tip, the applied current would 
need to be around 0.3 mA. Milliamp currents are regularly used in patients with deep brain 
stimulation (DBS), with a 25.5 mA current passed through a 0.06 cm2 electrode surface resulting 
in a current density of 4,250 A/m2.217 Therefore, there is considerable opportunity to increase the 
applied electrical current in this system with a 100 μm diameter capillary tip, and ultimately 
increase the flow rate from the capillary and eventually the Vd achieved by electrokinetic 
transport. 
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A number of interesting observations were compiled during the course of these in vivo 
experiments. Before the evaluation of volumetric data was attempted from thalamic infusions, a 
number of hippocampal infusions were conducted. The tissue volume of the hippocampus is 
much less than the thalamus, and in the case of Ru(bpy)32+ the hippocampal tissue margins were 
always reached during 25.0 μA ejections over 45 minutes with a 100 μm diameter capillary tip. 
As such, these infusions were not included in the volumetric data presented in Table 5.1. 
Nonetheless, migration of Ru(bpy)32+ was observed along several points of tissue connections. 
As shown in Figure 5.12, hippocampal infusions of Ru(bpy)32+ resulted in transport into 
the contralateral hippocampus and other adjacent areas through points where the tissue was 
physically (and biologically) connected or even simply touching, such as through the posterior 
sections of the corpus callosum. The posterior portion of the corpus callosum has two orthogonal 
linescans drawn through it in Figure 5.12. The infusion capillary was inserted into the 
hippocampus at the left, 300 μm anterior to the plane of this image. In the top right panel of 
Figure 5.12, the vertical linescan was evaluated. Appreciable fluorescence was observed 
primarily within the posterior corpus callosum tissue connection, but nowhere else. This 
fluorescence extends into the contralateral hippocampus (and towards the site of the counter 
capillary), as described by the bottom right panel that describes the horizontal linescan. Building 
upon sections 5.3.2 and 5.3.3, this transport through connected and adjacent tissue was likely 
related to the current path, as some anisotropy appears to exist in the transport of Ru(bpy)32+ with 
preferential movement towards the contralateral hippocampus with the counter capillary. 
Meanwhile, this same phenomenon seemed to hold for thalamic infusions also. Figure 
5.13 demonstrates transport of Ru(bpy)32+ through tissue connections towards the contralateral 
thalamus and counter capillary. In this case, the massa intermedia (interthalamic adhesion) was 
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appreciably fluorescent, while the surrounding milieu approximated the baseline fluorescence 
intensity. The infusion capillary tract may be visualized in Figure 5.13. The top right panel of 
Figure 5.13 quantifies an appreciable fluorescence through the roughly 600 μm thick 
interthalamic adhesion that exists between the two thalami (linescan taken along the skewed 
vertical line). The bottom right panel shows the fluorescence intensity plot along the 
interthalamic adhesion (linescan taken along the skewed horizontal line), whereby there was a 
gradual decrease in fluorescence intensity as Ru(bpy)32+ was transported towards the 
contralateral thalamus from the ipsilateral thalamus with a higher Ru(bpy)32+ concentration. 
 
 
Figure 5.12. Example in vivo ejection of Ru(bpy)32+ into the rat hippocampus with 25.0 μA applied current for 45 
minutes with bright field (top left) and fluorescence (bottom left). The right panels represent the fluorescence 
intensity along the vertical (top right) and horizontal (bottom right) white linescans. The green scale bar is 1,000 μm. 
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Figure 5.13. Example in vivo ejection of Ru(bpy)32+ into the rat thalamus with 25.0 μA applied current for 45 
minutes with bright field (top left) and fluorescence (bottom left). The right panels represent the fluorescence 
intensity along the skewed vertical (top right) and skewed horizontal (bottom right) white linescans. The green scale 
bar is 1,000 μm. 
 
These two examples for hippocampal and thalamic infusions provide an interesting point 
for further research. Control of electrokinetic transport along a current path was previously 
elucidated in hydrogels164 and OHSC. The data presented in this section provided some 
additional evidence that electrokinetic transport may be directed in vivo as well, with migration 
of a molecule along a current path towards a counter capillary positioned in the contralateral 
hippocampus or thalamus. The preferential transport of a molecule through the tissue may be 
contrasted with pressure-driven infusion.195, 202, 203, 205-212 Tissue deformation and tearing, 
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backflow along catheter tracts, and the overall propensity for fluid to move along paths of least 
pressure resistance obfuscated clinical trial results, as discussed in Chapter 4. With all of the 
electrokinetic infusions, no visible tissue deformation or tearing occurred due to the volume of 
infusate. However, there was residual damage from implantation of the infusion and counter 
capillaries, which was visualized in some instances. However, the extent of damage resulting 
from capillary implantation in the small rat brain (and resulting neurological deficit) would likely 
be negligible in the much larger human brain. 
5.4 CONCLUSIONS AND FUTURE DIRECTIONS 
This chapter utilized fused silica capillaries with a more negative ζ-potential170-173 and larger tip 
radii than presented in Chapter 3 with borosilicate capillaries. These modifications allowed for a 
significantly greater penetration distance to be achieved in hydrogels and OHSC. A range of 
applied currents was examined to deliver reproducible infusions of a small, highly charged 
molecule from a capillary tip. This methodology was further developed to rapidly infuse large 
surface areas from a hydrogel doped with a molecule of interest. Control of directional transport 
was also observed over several hundred micrometers to millimeters in OHSC. Finally, this work 
culminated in an in vivo proof-of-principle in the adult rat brain, whereby the ratio of the volume 
of distribution to volume of infusion by electrokinetic infusions were compared to those from 
pressure-driven infusions. With these in vivo experiments, a series of three molecules of varying 
electrophoretic mobilities and molecular weights were ejected to demonstrate the resilience of 
electrokinetic transport, and the effect of the tortuosity and its related frictional drag force, on 
achieving an ultimate volume of distribution. Anisotropic transport was observed in some 
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instances, whereby a molecule was directed towards the contralateral side (and counter capillary) 
through tissue connections. 
These experiments, as are typical in scientific research, open the door for additional 
investigation. In particular, due to instrument limitations, applied currents greater than 25.0 μA 
were not evaluated. It is possible to utilize higher current densities in vivo than were examined in 
the present work.164, 216, 217 Therefore, there is considerable opportunity to increase the applied 
current, as instrumentation allows. 
Increasing the capillary tip size has also been shown to result in a dramatic increase of the 
penetration distance of a molecule. Doubling the capillary diameter for equivalent current 
ejections of Ru(bpy)32+ into hydrogels yielded an approximately three-fold increase in the 
penetration distance. This relationship is hypothesized to be linear, and therefore it may be 
possible to achieve even greater volumes of tissue impacted as a result of ejections from a larger 
diameter capillary tip. 
Longer infusion times may also be evaluated in vivo. Clinical pressure-driven infusions 
typically proceed over several hours, whereas our maximum infusion time was only 45 minutes 
(to prevent hydrogel and tissue dehydration). Our ejections in vivo were not at steady-state, 
despite fitting Equation 5.1 with good correlation, therefore it was difficult to make comparisons 
based on time. The time to steady-state increases for larger capillary tip diameters and greater 
applied electrical currents. 
Finally, directional transport in vivo may be further evaluated, building from the several 
examples presented in this dissertation. For example, larger volumes of tissue may be impacted 
by the implantation of multiple capillaries spaced at given intervals to afford overlap of the 
electric field lines. In this instance, directional transport of a molecule may be controlled with 
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greater accuracy. Perfusion of a surgical resection bed or natural tissue cavity from a doped 
hydrogel may allow rapid conveyance of a molecule to wide areas of tissue. These hypotheses all 
warrant additional investigation to further delineate the robust nature of this methodology. 
In conclusion, this chapter described electrokinetic transport over wide tissue areas with 
considerable volumes of impacted tissue, with comparison to pressure-driven infusion. Because 
electrokinetic transport impacted a substantially greater volume of tissue than by diffusion alone, 
it represents a novel form of convection-enhanced delivery. Future investigation will focus on 
the application of this methodology to malignant brain gliomas, though it remains pertinent to all 
matrices with a ζ-potential and the capacity for electrokinetic transport. 
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